Document:

Warrant, dated as of May 25, 2012

 Exhibit 4.3 
 Execution Version 
 THE SECURITIES REPRESENTED BY THIS WARRANT HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES REPRESENTED BY THIS WARRANT HAVE BEEN ACQUIRED FOR INVESTMENT AND MAY NOT BE OFFERED, SOLD,
TRANSFERRED OR ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR AN OPINION OF COUNSEL, REASONABLY SATISFACTORY TO THE COMPANY, THAT REGISTRATION IS NOT REQUIRED UNDER THE SECURITIES ACT OR APPLICABLE STATE
SECURITIES LAWS UNLESS SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES ACT. THE SECURITIES REPRESENTED BY THIS WARRANT ARE SUBJECT TO THE TERMS AND CONDITIONS OF, AND MAY ONLY BE TRANSFERRED IN ACCORDANCE WITH, THE TERMS OF THIS WARRANT. 

LIGHTING SCIENCE GROUP CORPORATION 
 WARRANT TO PURCHASE COMMON STOCK 
  

					
	 Warrant No.: RW1
	  	 	Number of Shares: 18,092,511	  

 Issuance Date: May 25, 2012  
 THIS CERTIFIES THAT, for value received, RW LSG Management Holdings LLC (the “Holder”) is entitled to purchase from Lighting Science Group Corporation, a Delaware corporation (the
“Company”), at any time and from time to time during the applicable Warrant Exercise Period (defined below) at the Exercise Price (defined below) 18,092,511 fully paid nonassessable shares of Common Stock (defined below) (as
may be adjusted from time in accordance with the terms of this Warrant, the “Warrant Shares”), all subject to adjustment and upon the terms and conditions provided herein. This Warrant is being issued to the Holder in
connection with the Subscription Agreement, dated May 25, 2012, by and between the Holder and the Company. 

Section 1. Definitions. 
 The following terms as used in this Warrant have the following meanings: 
 (a)
“Acquiring Entity” has the meaning attributed to it in Section 8. 
 (b)
“Affiliate” of, or a Person “Affiliated” with, a specified Person, is a Person that directly or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control
with, the Person specified. 

 (c) “Business Day” means any day other than Saturday, Sunday or
other day on which commercial banks in New York, New York or San Francisco, California are authorized or obligated to close. 

(d) “Capital Stock” means any of the Company’s shares of Common Stock or preferred stock or any other
Derivative Security of the Company. 
 (e) “Change of Control” means (i) the sale, conveyance or
disposition, including but not limited to any spin-off or in-kind distribution, by the Company or by one or more of its subsidiaries, of all or substantially all of the assets of the Company (on a consolidated basis) to any Person or group (other
than the Company or its wholly-owned subsidiaries and other than pursuant to a joint venture arrangement in which the Company, directly or indirectly, receives at least fifty percent (50%) of the equity and voting interests); (ii) the
effectuation of a transaction or series of related transactions in which more than thirty-five percent (35)% of the voting power of the Company is disposed of (other than (A) as a direct result of normal, uncoordinated trading activities in the
Common Stock generally or (B) solely as a result of the disposition by a stockholder of the Company to an Affiliate of such stockholder); (iii) any merger, consolidation, stock or asset purchase, recapitalization or other business
combination transaction (or series of related transactions) as a result of which the shares of Capital Stock entitled to vote generally in the election of directors and the Preferred Shares (treated on an as-converted basis) immediately prior to
such transaction (or series of related transactions) are converted into and/or continue to represent (on an as-converted basis), in the aggregate, less than sixty-five percent (65%) of the total voting power of all shares of capital stock that
are entitled to vote generally in the election of directors of the entity surviving or resulting from such transaction (or ultimate parent thereof); (iv) a transaction or series of transactions in which any Person, entity or “group”
(as such term is used in Sections 13(d) and 14(d) of the Exchange Act) acquires more than thirty-five percent (35)% of the voting equity of the Company (other than the acquisition by a Person, entity or “group” that is an Affiliate of or
Affiliated with a Person, entity or “group” that immediately prior to such acquisition, beneficially owned thirty-five percent (35)% or more of the voting equity of the Company) or (v) Pegasus ceases to beneficially own in the
aggregate at least ten percent (10%) of the outstanding Capital Stock of the Company, on a fully-diluted basis. 
 (f)
“Common Stock” means (i) the Company’s common stock, $0.001 par value per share, and (ii) any capital stock into which the Common Stock is changed or any capital stock resulting from a reclassification of the
Common Stock. 
 (g) “Delivery Date” has the meaning attributed to it in Section 2(c).

 (h) “Derivative Security” means any right, option, warrant, convertible preferred stock or other
security or right convertible into or exercisable or exchangeable for shares of Common Stock. 
 (i) “Effective
Consideration” means the amount paid or payable to acquire shares of Common Stock (or, in the case of Derivative Securities, the amount paid or payable to acquire the Derivative Security, if any, plus the exercise price for the
underlying Common Stock). 

  
 2 

 (j) “Ex-Date” means (i) when used with respect to any issuance
or distribution, the first date on which the Common Stock trades, regular way, on the relevant Trading Market or such other market without the right to receive such issuance or distribution, and (ii) when used with respect to any subdivision,
split, combination or reclassification of shares of Common Stock, the first date on which the Common Stock trades, regular way, on such Trading Market or such other market after the time at which such subdivision, split, combination or
reclassification becomes effective. 
 (k) “Exchange Act” means the Securities Exchange Act of 1934, as
amended. 
 (l) “Exercise Date” has the meaning attributed to it in Section 2(c).

 (m) “Exercise Documents” has the meaning attributed to it in Section 2(c). 

(n) “Exercise Notice” has the meaning attributed to it in Section 2(a)(i). 

(o) “Exercise Price” is equal to the price computed using the following formula (for the avoidance of doubt,
Exercise Price shall be determined after all other adjustments to the number of Warrant Shares are taken into account): 
  

 
 where: 
  

	 	CEqV	 means, as of any date, the Fair Market Value per share of Common Stock on the Trading Day immediately preceding the Exercise Date;

  

	 	RefEqV	 $500,000,000; provided, that such amount shall be increased by any cash amounts raised by the Company (net of costs and expenses) pursuant to
any issuance or sale of any Capital Stock; provided, further, that such amount shall be decreased by any cash amounts paid by the Company pursuant to any redemption, repurchase, retirement or other acquisition of, or dividends or
distributions in respect of, any Capital Stock; 

  

	 	WS	means, as of any date, the number of Warrant Shares issuable upon exercise of this Warrant; 

 

	 	TEqV	 means, as of any date, the dollar value computed using the following formula: 

 
 

 
  

	 	S0	 means, as of any date, the number of shares of Common Stock outstanding on a fully-diluted basis (accounting for all Derivative Securities using the
treasury stock method, which, for the avoidance of doubt, would include any shares of Common Stock into which any outstanding shares of preferred stock are convertible if the liquidation value of such preferred stock is less than the Fair Market
Value of the Common Stock issuable upon conversion thereof); provided, that for purposes of calculating the number of shares of 

  
 3 

	 	
Common Stock outstanding on a fully-diluted basis, up to 10,750,000 shares of Common Stock or Derivative Securities (as adjusted for any subdivision, split, combination or reclassification of
shares of Common Stock) issued after the Issuance Date to the executives, directors and employees of the Company in their capacity as such pursuant to an option, stock or other equity plan approved by the Board of Directors shall not be included in
such calculation. 

  

	 	PVAG	 means, as of any date, the aggregate value of all outstanding shares of any class or series of the Company’s preferred stock, calculated as the
greater of (i) the liquidation value of each outstanding share of preferred stock and (ii) if applicable, the Fair Market Value of all shares of Common Stock (determined prior to the Open for Business on such date) issuable upon conversion
of each share of preferred stock, excluding the value of any shares of preferred stock that are included in the calculation of
S0 under the treasury stock method;

 provided, that, if: 
  

 
 then this Warrant shall be deemed to have no value; 
 provided, further, that, if: 
  
 

 
 then the Exercise Price shall not be negative and shall be deemed to equal zero. 

(p) “Event of Default” means (a) any default by the Company or any of its subsidiaries under any mortgage,
indenture or instrument under which there may be issued or by which there may be secured or evidenced any Indebtedness for money borrowed by the Company or any of its subsidiaries, whether such Indebtedness now exists, or is created after the
Issuance Date, if that default: (i) is caused by a failure to pay the principal of, or interest or premium, if any, on, such Indebtedness prior to the expiration of any grace period provided pursuant to the terms of such Indebtedness on the
date of such default and (x) the aggregate amount unpaid equals $10.0 million or more or (y) the principal amount of such Indebtedness aggregates to $15.0 million or more; or (ii) results in the acceleration of such Indebtedness prior
to its express maturity, and, in each case, the principal amount of any such Indebtedness aggregates to $8.0 million or more; provided, that if such default is cured or waived or any such acceleration rescinded, or such Indebtedness is
repaid, within a period of ten (10) days from the continuation of such default beyond the applicable grace period or the occurrence of such acceleration, as the case may be, no Event of Default shall be deemed to have occurred; (b) any
material breach or default under the Series H Certificate of Designation; provided, that if such breach or default is cured or waived within a period of ten (10) days from the continuation of such breach or default beyond any applicable
grace period, no Event of Default shall be deemed to have occurred; and (c) any material breach of default under the 

  
 4 

 
certificate of designation with respect to the Company’s Series G Preferred Stock, the Series I Certificate of Designation or the certificate of designation of any other series of preferred
stock of the Company (other than the Series H Convertible Preferred Stock), in each case to the extent outstanding; provided, that in the case of this clause (c), if such breach or default is cured or waived within a period of ten
(10) days from the continuation of such breach or default beyond any applicable grace period, no Event of Default shall be deemed to have occurred. 
 (q) “Fair Market Value” means, as of any date with respect to a share of Common Stock, the Trading Price as of such date; provided, that if “Fair Market Value” is
being determined in connection with a transaction with an Acquiring Entity for which Section 8(a) or Section 8(b) applies, then the fair market value of a share of Common Stock shall be the value of the consideration payable
by such Acquiring Entity for each share of Common Stock; provided, further, that for accounting purposes only, to the extent that the “Fair Market Value” is not determinable in accordance with the foregoing provisions of this
definition, “Fair Market Value” means, as of any date with respect to a share of Common Stock, the fair market value of a share of Common Stock as determined in good faith by the Board of Directors of the Company. 

(r) “Indebtedness” means, with respect to the Company and its subsidiaries: (i) any liabilities for borrowed
money or amounts owed or indebtedness issued in substitution for or exchange of indebtedness for borrowed money; (ii) obligations evidenced by notes, bonds, debentures or other similar instruments; (iii) obligations under leases
(contingent or otherwise, as obligor, guarantor or otherwise) required to be accounted for as capitalized leases pursuant to generally accepted accounting principles; (iv) obligations for amounts drawn and outstanding under acceptances, letters
of credit, contingent reimbursement liabilities with respect to letters of credit or similar facilities; (v) any liability for deferred purchase price of property or services, contingent or otherwise, as obligor or otherwise, other than
accounts payable incurred in the ordinary course of business and (vi) any accrued and unpaid interest on, and any prepayment premiums, penalties or similar contractual charges in respect of, any of the foregoing. 

(s) “Issuance Date” means May 25, 2012. 

(t) “Open of Business” means 9:00 a.m. New York City time. 

(u) “Payment” has the meaning attributed to it in Section 2(a)(ii). 

(v) “Pegasus” means Pegasus Capital Advisors, L.P. and its Affiliates. 

(w) “Permitted Transfer” means any transfer by Holder of all or any portion of this Warrant or all or any portion
of the Common Stock issued upon exercise of this Warrant: (i) to any Affiliate or direct or indirect equityholder of Holder or any of its Affiliates, (ii) to Pegasus, (iii) to the Company or any of the Company’s subsidiaries,
(iv) pursuant to the exercise of the co-sale rights set forth in that certain co-sale agreement, dated as of May 25, 2012, among Holder, Pegasus and certain of their Affiliates, (v) in any transaction in which all or substantially all
of the equity interests of the Company are transferred pursuant to any reorganization, merger, consolidation or sale of the Company, (vi) in a Qualified Public Offering or in another offering registered pursuant to the Securities Act after a
Qualified Public Offering, (vii) pursuant to a tender or exchange offer pursuant to the Securities Act or the Exchange Act, (viii) with the prior written consent of the Company or (ix) pursuant to a pro rata in-kind distribution or
dividend to the equityholders of Holder (and any intermediary transfers amongst Affiliates of Holder as part of giving effect thereto. 

  
 5 

 (x) “Person” means a natural person or entity, or a government or
any division, department or agency thereof. 
 (y) “Preferred Shares” means the Company’s shares of
Series H Convertible Preferred Stock and Series I Convertible Preferred Stock. 
 (z) “Qualified Public
Offering” means a firmly committed underwritten public offering of the Common Stock on the NASDAQ Stock Market or the New York Stock Exchange pursuant to an effective registration statement filed under the Securities Act, where
(a) the gross proceeds received by the Company and any selling stockholders in the offering are no less than $100 million and (b) the market capitalization of the Company immediately after consummation of the offering is no less than $500
million. 
 (aa) “Restrictive Period” has the meaning attributed to it in Section 6(a). 

(bb) “Riverwood” means Riverwood Capital Partners, L.P. and its Affiliates. 

(cc) “Securities Act” means the Securities Act of 1933, as amended. 

(dd) “Series G Holder” means any holder of the Company’s outstanding shares of Series G Preferred Stock.

 (ee) “Series H Certificate of Designation” means the Certificate of Designation of Series H
Convertible Preferred Stock of the Company, as filed with the Secretary of State of the State of Delaware and as the same may be amended, restated, supplemented or otherwise modified from time to time. 

(ff) “Series H Holder” means any holder of the Company’s outstanding shares of Series H Convertible
Preferred Stock. 
 (gg) “Series I Certificate of Designation” means the Certificate of Designation of
Series I Convertible Preferred Stock of the Company, as filed with the Secretary of State of the State of Delaware and as the same may be amended, restated, supplemented or otherwise modified from time to time. 

(hh) “Series I Holder” means any holder of the Company’s outstanding shares of Series I Convertible
Preferred Stock. 
 (ii) “Trading Day” means a day on which the Common Stock is traded on a Trading
Market. 
 (jj) “Trading Market” means The NASDAQ Stock Market or the New York Stock Exchange.

  
 6 

 (kk) “Trading Price” means, for any date, the price determined by
the first of the following clauses that applies: 
 (i) after a Qualified Public Offering, the closing sale price
or, if no closing sale price is reported, the last reported sale price of the Common Stock for such date (or the nearest preceding date) on the principal Trading Market on which the Common Stock is listed or quoted for trading as reported by
Bloomberg, L.P. (based on a Trading Day from 9:30 a.m. (New York City time) to 4:02 p.m. (New York City time)); or 
 (ii) in all other cases, the fair market value of a share of Common Stock as determined by an independent appraiser selected in good faith by the Holder and reasonably acceptable to the Company, the fees
and expenses of which shall be paid by the Company. 
 (ll) “Warrant” means this Warrant and all
Warrants issued in exchange, transfer or replacement thereof. 
 (mm) “Warrant Exercise Period” has the
meaning attributed to it in Section 2(a). 
 (nn) “Warrant Shares” has the meaning
attributed to it in the preamble of this Warrant, as may be adjusted from time to time in accordance with this Warrant. 

Section 2. Exercise of Warrant. 
 (a) This Warrant may be exercised, to the extent permitted by applicable laws and regulations, for Warrant Shares, in whole or in part, by the Holder registered on the books of the Company at any time on
or before 5:00 p.m., New York City time on May 25, 2022 (the “Warrant Exercise Period”). Any exercise of this Warrant shall be effected by: 

(i) delivery of a written notice, in the form attached as Exhibit A (the “Exercise
Notice”), of Holder’s election to exercise this Warrant with respect to the Warrant Shares; 

(ii) payment to the Company of an amount equal to the Exercise Price (determined as of the close of business on the
Trading Day prior to exercise) multiplied by the number of Warrant Shares being purchased, either (A) in cash or by wire transfer of immediately available funds or (B) by means of a cashless exercise pursuant to Section 2(d)
(the foregoing methods of payment set forth in (A) and (B), including any combination of such methods, referred to herein as the “Payment”); and 

(iii) the surrender at the principal office of the Company or to a nationally recognized courier for overnight delivery to
the Company, simultaneously with or as soon as practicable following the delivery of the Exercise Notice and the Payment, of this Warrant (or an indemnification undertaking with respect to this Warrant in the case of its loss, theft or destruction,
in such form and substance as is reasonably satisfactory to the Company). 

  
 7 

 (b) If the Holder does not exercise this Warrant in its entirety, the Holder will be
entitled to receive from the Company within a reasonable time, and in any event not exceeding five (5) Business Days, a new warrant in substantially identical form for the purchase of that number of shares of Common Stock equal to the
difference between the number of shares of Common Stock subject to this Warrant and the number of shares of Common Stock as to which this Warrant is so exercised. Notwithstanding anything in this Warrant to the contrary, the Holder hereby
acknowledges and agrees that its exercise of this Warrant for shares of Common Stock is subject to the condition (for the benefit of the Company and the Holder) that the Holder will have first received any applicable regulatory approvals required to
be obtained by Holder with respect to such exercise of the Warrants and issuance of the Warrant Shares. Unless the rights represented by this Warrant have expired or been fully exercised, the Company shall, as soon as practicable and in no event
later than five (5) Business Days after receipt of the Exercise Documents and at its own expense, issue a new Warrant identical in all respects to this Warrant, except it shall represent rights to purchase the number of Warrant Shares
purchasable immediately prior to exercise, less the number purchased. 
 (c) The Company shall, not later than the fifth
(5th) Business Day (the “Delivery Date”) following receipt of an Exercise Notice, the Payment and this Warrant or such indemnification (collectively, the “Exercise Documents”), arrange for its
transfer agent, on or before the Delivery Date, to issue and surrender to a nationally recognized courier for overnight delivery to the address specified in the Exercise Notice, a certificate, registered in the name of the Holder or its permitted
designee, for the number of shares of Common Stock to which the Holder is entitled. Upon delivery of the Exercise Notice and the Payment (the “Exercise Date”), the Holder shall be deemed for all corporate purposes to have
become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised on the Delivery Date, irrespective of the date of delivery of the certificates evidencing such Warrant Shares. 

(d) In lieu of or in addition to exercising this Warrant and making the Payment in cash or by wire transfer pursuant to
Section 2(a)(ii)(A), the Holder may elect to make the Payment by means of receiving shares of Common Stock equal to the value of this Warrant (or portion thereof being exercised) by delivery and surrender of the Warrant together with the
Exercise Notice in accordance with the terms hereof, duly completed to indicate a net issuance exercise and executed by the Holder, in which event the Company shall issue to the Holder a number of shares of Common Stock computed using the following
formula: 
  
 

 
 where: 
  

	 	S	equals the number of shares of Common Stock to be issued as Warrant Shares to the Holder; 

 

	 	WS0	 means, as of any date, the number of Warrant Shares purchasable (or portion thereof) under this Warrant that are being exercised at the applicable date
of determination; 

  
 8 

	 	CEqV	 means, as of any date, the Fair Market Value per share of Common Stock on the Trading Day immediately preceding the Exercise Date (for the avoidance of
doubt, CEqV as used in this equation must equal CEqV used for purposes of determining the Exercise Price); and

  

	 	E	the Exercise Price on the Exercise Date. 

 (e) No fractional shares of Common Stock or scrip representing fractional shares of Common Stock shall be issued upon any exercise of this Warrant. In lieu of any fractional share of Common Stock to which
the Holder would otherwise be entitled, the Company shall issue a number of shares of Common Stock to Holder rounded up to the nearest whole number of shares of Common Stock. No cash shall be payable to any Holder upon exercise of the Warrant
Shares. 
 (f) This Warrant shall not be exercisable for any shares (and, for the avoidance of doubt, shall have no other value)
if, in accordance with, and solely to the extent and in the circumstances specifically provided in, the definition of “Exercise Price,” this Warrant is “deemed to have no value”. 

Section 3. Representations, Warranties, Covenants and Agreements. The Company hereby represents, warrants, covenants and
agrees, as applicable, as follows: 
 (a) This Warrant is, and any Warrants issued in substitution for or in replacement of this
Warrant upon issuance will be, duly authorized, executed and delivered. 
 (b) All shares of Common Stock issuable upon exercise
of this Warrant have been duly authorized and when issued upon such exercise will be validly issued, fully paid and nonassessable and free from all taxes, liens and charges with respect to the issue thereof. 

(c) As long as this Warrant may be exercised, the Company will at all times have authorized and reserved for issuance and delivery upon
exercise of this Warrant at least the number of shares of Common Stock needed to provide for the exercise in full of the rights then represented by this Warrant. 
 (d) The Company will use its reasonable best efforts to ensure that the Common Stock may be issued without violation of any law or regulation applicable to the Company or of any requirement of any
securities exchange applicable to the Company on which the shares of Common Stock are listed or traded. 
 Section 4.
Warrant Holder Not Deemed a Stockholder. Nothing contained in this Warrant shall be construed to (a) grant the Holder any rights to vote or receive dividends or be deemed the holder of shares of the Company for any purpose,
(b) confer upon the Holder any of the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger,
conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, or (c) impose any liabilities on the Holder to purchase any securities or as a stockholder of the Company, whether asserted by the
Company or creditors of the Company, prior to the exercise hereof. 

  
 9 

 Section 5. Representations of Holder. The Holder, by the acceptance hereof,
represents that it is acquiring this Warrant and the Warrant Shares for its own account for investment only and not with a view towards, or for resale in connection with, the public sale or distribution of this Warrant or the Warrant Shares, except
pursuant to sales registered or exempted under the Securities Act. Upon exercise of this Warrant, the Holder shall, if requested by the Company, confirm in writing, in a form satisfactory to the Company, that the Warrant Shares are being acquired
solely for the Holder’s own account and not as a nominee for any other party, for investment, and not with a view toward distribution or resale. If Holder cannot make such representations because they would be factually incorrect, it shall be a
condition to Holder’s exercise of this Warrant that the Company receives such other representations as the Company considers reasonably necessary to assure the Company that the issuance of its securities upon exercise of this Warrant shall not
violate any federal or state securities laws. The Company shall not be penalized or disadvantaged by the Holder’s inability to exercise this Warrant due to its inability to make the required representations in connection with the exercise of
this Warrant. 
 Section 6. Ownership and Transfer. 

(a) (a) This Warrant, and any shares of Common Stock issued upon exercise of this Warrant, may be offered, sold, transferred or
assigned by any Holder to a transferee in a Permitted Transfer. Subject to this Section 6, during the Restrictive Period, this Warrant, and any shares of Common Stock issued upon exercise of this Warrant, may not be offered, sold,
transferred or assigned by any Holder except pursuant to a Permitted Transfer. As used herein, the “Restrictive Period” shall mean the period commencing on the Issuance Date and ending upon the earliest of (A) the three-year
anniversary of the Issuance Date, (B) a Qualified Public Offering and (C) an Event of Default. 
 (b) To the extent
the Restrictive Period ends by reason of the occurrence of the three-year anniversary of the Issuance Date as provided in clause (i) of the definition thereof, and neither a Qualified Public Offering nor an Event of Default has occurred, this
Warrant, and any shares of Common Stock issued upon exercise of this Warrant, may only be offered, sold, transferred or assigned by any Holder with the prior written consent of the Company, such consent not to be unreasonably withheld, conditioned
or delayed, or pursuant to a Permitted Transfer. 
 (c) All offers, sales, transfers and assignments of this Warrant, or any
shares of Common Stock issued upon exercise of this Warrant must also be made in accordance with the Securities Act, and applicable state securities laws. Any attempted transfer of this Warrant, or any shares of Common Stock issued upon exercise of
this Warrant, in violation of this Section 6 shall be null and void ab initio. 
 (d) Subject to
Section 6(a), upon surrender of this Warrant to the Company, together with instructions by the applicable Holder that all or a portion of this Warrant be assigned, the Company shall, without charge, execute and deliver a new Warrant in
the name of the assignee or assignees named in such instrument of assignment and, if the applicable Holder’s entire interest is not being assigned, in the name of the Holder and this Warrant shall promptly be canceled. All expenses (other than
stock transfer taxes) and other charges payable in connection with the preparation, execution and delivery of the new Warrants pursuant to this Section 6(b) shall be paid by the Company. 

  
 10 

 (e) Issuance of certificates for Warrant Shares (or other securities) to the Holder upon
exercise of this Warrant shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such certificates, all of which taxes and expenses shall be paid by the Company. 

(f) The Company shall maintain a registry showing the name and address of the Holder as the registered holder of this Warrant, and the
Company shall be entitled to rely in all respects, prior to written notice to the contrary, upon such registry. This Warrant is exchangeable, upon the surrender hereof by the Holder to the Company, for a new Warrant or Warrants of like tenor and
representing the right to purchase the same aggregate number of Warrant Shares. 
 Section 7. Adjustment of Number of
Warrant Shares. 
 (a) In the event of any issuance of Common Stock as a dividend or distribution to all holders of Common
Stock, or a subdivision, split, combination or reclassification of the outstanding shares of Common Stock into a greater or smaller number of shares, the number of Warrant Shares for which this Warrant is exercisable shall be adjusted pursuant to
the following formula: 
  
 

 
 where: 
  

	 	WS =	the number of Warrant Shares for which this Warrant is exercisable immediately after the Open of Business on the Ex-Date for such dividend or distribution, or
immediately after the Open of Business on the effective date for such subdivision, combination or reclassification, as the case may be; 

  

	 	WS0 =	 the number of Warrant Shares for which this Warrant is exercisable immediately prior to the Open of Business on the Ex-Date for such dividend or
distribution, or immediately prior to the Open of Business on the effective date for such subdivision, combination or reclassification, as the case may be; 

 

	 	N0 =	 the number of shares of Common Stock outstanding immediately prior to the Open of Business on the Ex-Date for such dividend or distribution, or
immediately prior to the Open of Business on the effective date for such subdivision, combination or reclassification, as the case may be; and 

  

	 	N1 =	 the number of shares of Common Stock equal to (i) in the case of a dividend or distribution, the sum of (A) the number of shares outstanding
immediately prior to the Open of Business on the Ex-Date for such dividend or distribution plus (B) the total number of shares issued pursuant to such dividend or distribution or (ii) in the case of a subdivision, combination or
reclassification, the number of shares outstanding immediately after such subdivision, combination or reclassification. 

  
 11 

 Such adjustment shall become effective (i) in the case of a dividend or distribution,
immediately after the Open of Business on the Ex-Date for such dividend or distribution or (ii) in the case of a subdivision, split, combination or reclassification, immediately after the Open of Business on the effective date for such
subdivision, split, combination or reclassification. If any dividend or distribution or subdivision, split, combination or reclassification of the type described in this Section 7(a) is declared or announced but not made, the number of
Warrant Shares for which this Warrant is exercisable shall again be adjusted to the number of Warrant Shares that would then be in effect if such dividend or distribution or subdivision, split, combination or reclassification had not been declared
or announced, as the case may be. 
 (b) In the event of (w) any or a subdivision, split, combination or reclassification
of the outstanding shares of Common Stock, (x) any declaration or making of a dividend or other distribution to holders of Common Stock, (y) the dissolution, liquidation or winding up of the Company, or (z) the entry into, or
commitment by the Company to effect, any event described in clauses (a) or (b) of Section 8 (including a Change of Control), then the Company shall file with its corporate records and mail to the Holder at its last address as
shown on the records of the Company, at least ten (10) days prior to the record or other date specified below, a notice stating: 
 (i) the record date of such split, dividend or other distribution, or, if a record is not to be taken, the date as of which the holders of Common Stock of record to be entitled to such subdivision, split,
combination or reclassification, dividend or other distribution are to be determined; or 
 (ii) the date on
which such subdivision, reclassification, liquidation, dissolution, winding up, combination, event, transaction or Change of Control, is estimated to become effective, and the date as of which it is expected that holders of Common Stock of record
will be entitled to exchange their shares of Common Stock for the capital stock, other securities or other property (including but not limited to cash and evidences of indebtedness) deliverable upon such subdivision, reclassification, liquidation,
dissolution, winding up, combination, event, transaction or Change of Control. 
 (c) Upon the occurrence of each adjustment or
readjustment of the number of Warrant Shares pursuant to this Section 7, the Company at its expense shall promptly as reasonably practicable compute such adjustment or readjustment in accordance with the terms hereof and furnish to each
Holder a certificate, signed by an executive officer of the Company, setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based and shall file a copy of such certificate with its
corporate records. The Company shall, upon the reasonable written request of any Holder, furnish to such Holder a similar certificate setting forth (i) the calculation of such adjustments and readjustments in reasonable detail and (ii) the
number of shares of Common Stock and the amount, if any, of capital stock, other securities or other property (including but not limited to cash and evidences of indebtedness) which then would be received upon the exercise of this Warrant.

 Section 8. Purchase Rights; Reorganization, Reclassification, Consolidation, Merger or Sale. Upon the
consummation of any (a) sale of all or substantially all of the Company’s assets to an acquiring Person or (b) other Change of Control following which the Company is not a surviving entity, the Company will secure from the Person
purchasing the assets or the successor 

  
 12 

 
resulting from the Change of Control (in each case, the “Acquiring Entity”) a written agreement to deliver to the Holder, in exchange for this Warrant, a security of the
Acquiring Entity evidenced by a written instrument substantially similar in form and substance to this Warrant and reasonably satisfactory to the Holder. Prior to the consummation of any other Change of Control, the Company shall make appropriate
provision to insure that the Holder will thereafter have the right to acquire and receive, in lieu of the shares of Common Stock immediately theretofore acquirable and receivable upon the exercise of this Warrant, such shares of stock, securities or
assets that would have been issued or payable in the Change of Control with respect to or in exchange for the number of Warrant Shares that would have been acquirable as of the date of the Change of Control. 

Section 9. Lost, Stolen, Mutilated or Destroyed Warrant. If this Warrant is lost, stolen, mutilated or destroyed, the Company
shall promptly, on receipt of an indemnification undertaking reasonably satisfactory to the Company (or, in the case of a mutilated Warrant, the Warrant), issue a new Warrant of like denomination and tenor as this Warrant so lost, stolen, mutilated
or destroyed. 
 Section 10. Notice. Any notices, consents, waivers or other communications required or permitted to
be given under the terms of this Warrant must be in writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; (ii) upon receipt, when sent by fax (provided confirmation of transmission is mechanically
or electronically generated and kept on file by the sending party); or (iii) one (1) Business Day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive the same. The
addresses, fax numbers and email addresses for communications shall be: 
 If to the Company: 

Lighting Science Group Corporation 

1227 South Patrick Drive 
 Building 2A 
 Satellite Beach, FL 32937 

Attention: Gregory T. Kaiser, Chief Financial Officer 

Fax: (321) 779-5521 
 With a copy (which shall not constitute notice or constructive notice) to: 
 Haynes and Boone, LLP 
 2323 Victory Avenue, Suite 700 

Dallas, TX 75219 
 Attention: Greg R. Samuel, Esq. 
 Fax: (214) 200-0577

 If to the Holder: 
 c/o Riverwood Capital Management L.P. 
 70 Willow Road, Suite 100

 Menlo Park, CA 94025 
 Attention: Jeffrey T. Parks 
 Fax: (650) 618-7114 

  
 13 

 With a copy (which shall not constitute notice or constructive notice) to: 

Simpson Thacher & Bartlett LLP 

2550 Hanover Street 
 Palo Alto, CA 94304 
 Attention: Kirsten Jensen 

Fax: (650) 251-5002 
 Each party shall provide five (5) days’ prior written notice to the other party of any change in address or fax number or email address. Written confirmation of receipt (A) given by the
recipient of any notice, consent, waiver or other communication, (B) mechanically or electronically generated by the sender’s fax machine or computer containing the time, date, recipient fax number or email address and an image of the
first page of the fax transmission or the content of the email, or (C) provided by a nationally recognized overnight delivery service, shall be rebuttable evidence of receipt. 

Section 11. Amendment and Waiver. This Warrant may not be modified or amended except pursuant to an instrument in writing
signed by the Company and the Holder. No provision hereunder may be waived other than in a written instrument executed by the waiving party. No failure or delay by either party in exercising any right, power or privilege hereunder shall operate as a
waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of
any rights or remedies provided by law. 
 Section 12. Governing Law. This Warrant shall be construed and enforced
in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal laws of the State of New York, without giving effect to any choice of law or conflict of
law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. 

Section 13. Restrictive Legends. At all times this Warrant, and until such time as a registration statement has been declared
effective by the U.S. Securities and Exchange Commission or the Warrant Shares may be sold pursuant to Rule 144 under the Securities Act without any restriction as to the number of securities that can then be immediately sold, certificates for any
Warrant Shares will, in addition to any legend required under applicable securities law, bear a restrictive legend substantially in the form set forth on the first page of this Warrant. 

Section 14. Binding Effect. This Warrant shall be binding upon any successors or assigns of the Company. 

Section 15. Entire Agreement. This Warrant and the Support Services Agreement entered into between the Company and Holder and
dated as of the Issuance Date (and the other documents referenced therein), contain the entire agreement between the parties with respect to the 

  
 14 

 
subject matter hereof and supersede all prior and contemporaneous arrangement or undertakings with respect thereto. 
 *    *    *    *    * 

  
 15 

 IN WITNESS WHEREOF, the Company has caused this Warrant to be signed as of May 25,
2012. 
  

			
	LIGHTING SCIENCE GROUP CORPORATION
		
	By:	 	/s/ Gregory T. Kaiser
	Name:	 	Gregory T. Kaiser
	Title:	 	Chief Financial Officer

 [Signature Page to Warrant] 

 Agreed and Acknowledged on May 25, 2012. 

 

			
	RW LSG MANAGEMENT HOLDINGS LLC
		
	By:	 	Riverwood Capital Management L.P.,
		 	its Managing Member
		
	By:	 	Riverwood Capital Management Ltd.,
		 	its General Partner
		
	By:	 	/s/ Michael E. Marks
		 	Name: Michael E. Marks
		 	Title: Director and CEO

  
 17 

 Exhibit A To Warrant 

LIGHTING SCIENCE GROUP CORPORATION 
 EXERCISE NOTICE 
 TO BE EXECUTED BY THE REGISTERED HOLDER 

TO EXERCISE THIS WARRANT 
 The undersigned holder hereby exercises the right to purchase                      shares of Common
Stock (“Warrant Shares”) of Lighting Science Group Corporation, a Delaware corporation (the “Company”), evidenced by the attached Warrant (the “Warrant”). Capitalized terms used herein and not
otherwise defined shall have the respective meanings set forth in the Warrant. 
  

	 	1.	Payment of Exercise Price (check applicable box). 

  

	 	    	Payment in the sum of $             is enclosed in accordance with the terms of the Warrant.

  

	 	‘	Payment in the sum of $             has been wire transferred to the Company at the following
account:                     in accordance with the terms of the Warrant. 

 

	 	    	Holder hereby elects to make the Payment for the Warrant Shares in accordance with Section 2(d) of the Warrant. 

 

	 	2.	Delivery of Warrant Shares. The Company shall deliver the Warrant Shares in the name of the undersigned or in such other name as is specified below in accordance
with Section 2(c) of the Warrant at the following address: 

Date:        ,                

			
		
	By:	 	 
		 	Name:
		 	Title:Preferred Stock Subscription Agreement, dated as of May 25, 2012

 Exhibit 10.1 
 Execution Version 
 PREFERRED STOCK SUBSCRIPTION AGREEMENT

 THIS PREFERRED STOCK SUBSCRIPTION AGREEMENT (as may be amended or modified from time to time in accordance with the terms
hereof, this “Agreement”) is entered into on May 25, 2012, by and among LIGHTING SCIENCE GROUP CORPORATION, a Delaware corporation (the “Company”), RW LSG HOLDINGS LLC, a Delaware limited
liability company (the “Primary Investor”) and the undersigned Purchasers (together with Primary Investor, the “Purchasers”). 
 WHEREAS, the Company has authorized two new series of preferred shares designated the “Series H Convertible Preferred Stock” (“Series H Preferred Stock”) and
“Series I Convertible Preferred Stock” (“Series I Preferred Stock” and together with the Series H Preferred Stock, the “Preferred Shares”), which will each be convertible into shares of
common Stock, $0.001 par value per share, of the Company (“Common Stock”) in accordance with the terms of the Certificate of Designation governing the Series H Preferred Stock, in the form attached hereto as Exhibit A
(the “Series H Certificate of Designation”), or the Series I Preferred Stock, in the form attached hereto as Exhibit B (the “Series I Certificate of Designation”), as applicable; 

WHEREAS, the Company desires to sell to each Purchaser and each Purchaser desires to buy from the Company the number of Preferred
Shares of the series of Preferred Shares set forth on Schedule A hereto, each at a purchase price of $1,000 per share and a stated value of $1,000 per share, on the terms set forth herein; and 

WHEREAS, certain capitalized terms as used herein shall have the meaning set forth in Section 6(a) hereof. 

NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto hereby agree as follows:

 1. Purchase and Sale of Preferred Shares. 

(a) Payment for Preferred Shares; Delivery of Certificates. Subject to the provisions of this Agreement, and
relying upon the representations, warranties and covenants set forth herein, each Purchaser hereby agrees to purchase from the Company, and the Company hereby agrees to sell to each Purchaser, the number of Preferred Shares set forth beside such
Purchaser’s name on Schedule A attached hereto (the “Purchased Shares”), free and clear of all Liens, for aggregate consideration equal to the total consideration set forth beside such Purchaser’s name on
Schedule A attached hereto (the “Purchase Price”). The closing of the purchase and sale of the Purchased Shares by each Purchaser (the “Closing”) shall occur concurrently with the execution
hereof. At the Closing: (i) each Purchaser shall transmit, or cause to be transmitted, by wire transfer of immediately available funds to the Company, in accordance with the wire transfer instructions previously delivered to each Purchaser an
amount equal to such Purchaser’s Purchase Price, (ii) the Company will deliver to each Purchaser certificates representing such Purchaser’s Purchased Shares in accordance with this Agreement, registered in the name of each Purchaser
in such denominations as such Purchaser shall request, (iii) each Purchaser shall deliver to the Company each of the Transaction Documents to which such 

 
Purchaser (and with respect to Primary Investor, Riverwood Management), is a party, duly executed by such Purchaser and/or Riverwood Management, as applicable, (iv) the Company shall deliver
or cause to be delivered to each Purchaser each of the Transaction Documents to which the Company and such Purchaser is a party, duly executed by each party thereto other than such Purchaser and Riverwood Management, and (v) the Company shall
cause to be delivered to each Purchaser an opinion of Haynes and Boone, LLP, counsel for the Company, in form and substance satisfactory to Primary Investor. 
 (b) Use of Purchase Price. Subject to the terms of the Series G Certificate of Designation, the proceeds of the aggregate Purchase Price paid by all Purchasers shall be used by the Company for
general corporate purposes, and up to $16.3 million of such proceeds may be used towards the redemption of preferred member interests held by Continental Casualty Company (or an Affiliate thereof) in LCGS Holdings LLC, pursuant to the terms of such
preferred member interests. 
 2. Company Representations and Warranties. The Company hereby represents and warrants to
each Purchaser as of the date hereof as follows, qualified by any specific disclosures made by the Company in the disclosure schedule of even date herewith delivered by the Company to each Purchaser simultaneously with the execution hereof,
referencing the particular subsection of this Section 2 (the “Disclosure Schedule”). The disclosures in any section or subsection of the Disclosure Schedule shall qualify each of the other sections and subsections
in this Section 2 only to the extent it is readily apparent from a reading of the disclosure that such disclosure is applicable to such other sections and subsections; provided that no disclosures in the Disclosure Schedule shall
be deemed to qualify Section 2(h) unless referenced in Section 2(h) of the Disclosure Schedule: 
 (a) Organization and Qualification. The Company is a corporation duly incorporated, validly existing and in good standing under the Laws of the State of Delaware. The Company has all licenses,
permits and authorizations necessary to own its properties, rights and assets and carry on its business as presently conducted and is duly qualified to do business as a foreign entity and in good standing in each state or country, if any, in which
failure to be so qualified would, individually or in the aggregate, have or reasonably be expected to have a Material Adverse Effect. The Company is not in violation of its Certificate of Incorporation or Bylaws. 

(b) Company Power. The Company has the requisite power and authority to execute, deliver and perform its
obligations under the Transaction Documents and all other instruments, documents and agreements contemplated or required by the provisions of any of the Transaction Documents to be executed, delivered or carried out by the Company hereunder. The
Company has the requisite corporate power and authority under the Laws of the State of Delaware to own its properties and carry on its business as presently conducted. 

(c) Subsidiaries. Section 2(c) of the Disclosure Schedule lists all Subsidiaries of the Company and
their respective jurisdictions of incorporation (collectively, the “Company Subsidiaries” and each, a “Company Subsidiary”). The Company owns, directly or indirectly, all the shares of outstanding
Capital Stock of each Company Subsidiary. There are no outstanding securities or rights convertible into or exchangeable 

  
 2 

 
for shares of any Capital Stock of any Company Subsidiary and there are no Contracts by which any Company Subsidiary is bound to issue additional shares of Capital Stock. All of the shares of
Capital Stock of each of the Company Subsidiaries are duly and validly authorized, fully paid and non-assessable and are owned by the Company free and clear of any Lien with respect thereto. Each Company Subsidiary is duly organized, validly
existing and in good standing under the Laws of its jurisdiction of organization and has all requisite corporate power and authority to own, operate and lease its properties and to carry on its business as it is now being conducted, and is duly
licensed or qualified to do business in each other jurisdiction in which it owns or leases properties, or conducts any business, so as to require such qualification, in each case except where the failure to be so licensed or qualified in any such
jurisdiction would, individually or in the aggregate, have or reasonably be expected to have a Material Adverse Effect. No Company Subsidiary is subject to any restriction on its ability to make distributions to its owners. 

(d) Authorization; Governmental Approvals. 

 

	 	i.	The execution and delivery of this Agreement and the other Transaction Documents, the consummation by the Company of the transactions herein and therein contemplated to
be consummated by the Company, the issuance, sale and delivery of the Purchased Shares to each Purchaser in accordance with this Agreement and the issuance and delivery of the shares of Common Stock issuable upon conversion of the Preferred Stock
(the “Conversion Shares”) in accordance with the terms of the Series H Certificate of Designation or Series I Certificate of Designation, as applicable, have each been duly authorized by all necessary corporate action on the
part of the Company. 

  

	 	ii.	Except for filings necessary for the sale of the Purchased Shares to qualify for certain exemptions from the registration requirements under state blue sky Laws and
federal securities Laws, no authorization, consent, approval, license or exemption of, and no registration, qualification, designation, declaration or filing with, any court or Governmental Body, and no vote, authorization, consent or approval of
the stockholders of the Company, is necessary for (A) the valid execution and delivery of this Agreement by the Company, (B) the execution, issuance and delivery of the Purchased Shares or Conversion Shares, (C) the execution and
delivery by the Company of the other Transaction Documents or (D) the consummation by the Company of the transactions herein and therein contemplated to be consummated by the Company. 

(e) Capital. The Purchased Shares will have the voting powers, designation, preferences, rights and privileges,
and the qualifications, limitations and restrictions thereof, set forth in the Series H Certificate of Designation or Series I Certificate of Designation, as applicable. The Company has reserved for issuance the Conversion Shares. The Purchased
Shares, when issued, sold, and delivered in accordance with the terms of this Agreement for the consideration expressed herein, will be duly authorized, validly issued and fully paid, and will be free of restrictions on use, voting or transfer or
Liens other than restrictions on transfer or Liens under the applicable state and federal 

  
 3 

 
securities Laws and pursuant to the Series H Certificate of Designation or Series I Certificate of Designation, as applicable. The issuance and sale of the Purchased Shares is not subject, and
will not be subject, to any preemptive rights. The Conversion Shares have been duly authorized, validly reserved for issuance, and upon issuance in accordance with the terms hereof and the provisions of the Series H Certificate of Designation or
Series I Certificate of Designation, as applicable, will be duly authorized, validly issued and fully paid, and will be free of restrictions on use, voting or transfer or Liens other than the restrictions on transfer or Liens under the applicable
state and federal securities Laws and pursuant to the Series H Certificate of Designation or Series I Certificate of Designation, as applicable, and will not be subject to any preemptive rights. 

(f) Validity and Binding Effect; No Conflicts. This Agreement and each of the other Transaction Documents to which
the Company is a party have been duly and validly executed and delivered by the Company and constitute the legal, valid and binding obligation of the Company, enforceable in accordance with their respective terms. The execution, delivery and
performance of this Agreement and the other Transaction Documents by the Company does not (i) conflict with, violate or cause a breach, termination, acceleration or modification of (with or without the giving of notice or the lapse of time, or
both) any of the terms, conditions or provisions of or constitute a default under (A) any provision of the organizational documents or Bylaws of the Company or any Company Subsidiary; (B) any Contract, Permit or Order to which the Company
or any Company Subsidiary is a party or by which the Company or any Company Subsidiary or any of their respective properties is bound; (C) any Law to which the Company or any Company Subsidiary is subject or by which the Company or any Company
Subsidiary or any of their respective properties is bound or; (ii) result in the creation or imposition of any Lien upon the properties or assets of the Company or any Company Subsidiary; other than in the case of the foregoing clauses (i)(B),
(i)(C) and (ii), such requirements, conflicts, violations, breaches or rights which would not, individually or in the aggregate, have or reasonably be expected to have a Material Adverse Effect. Other than those which have been obtained or made, no
Consent of any other Person is required on the part of the Company or the Company Subsidiaries in connection with the execution and delivery of this Agreement or the Transaction Documents, or the compliance by the Company with any of the provisions
hereof or thereof, or the consummation of the transactions contemplated hereby. 
 (g) Capitalization.

  

	 	i.	 Section 2(g)(i) of the Disclosure Schedule sets forth, a true, complete and correct listing of the following, immediately prior to the open
of business on the date hereof: (i) the authorized capitalization of the Company, the number of shares of each class of Capital Stock of the Company issued and outstanding and the number of shares reserved for issuance in connection with the
Company’s stock option plans or otherwise, and (ii) all options, warrants, rights to subscribe to, calls, contracts, undertakings, arrangements, Contracts and commitments to issue which may result in the issuance of Capital Stock of the
Company or other securities convertible into or exchangeable for shares of Capital Stock (the “Derivative Securities”), including the applicable exercise price of such

  
 4 

	 	
Derivative Securities. Except as set forth in Section 2(g) of the Disclosure Schedule, as of the open of business on the date hereof, there are (A) no outstanding shares of
Capital Stock of, or other equity or voting interest in, the Company, (B) no outstanding Derivative Securities, (C) no obligations of the Company to grant, extend or enter into any subscription, warrant, right, convertible or exchangeable
security or other similar Contract or commitment relating to any Capital Stock of, or other equity or voting interest (including any voting debt) in, the Company (the items in clauses (A), (B) and (C), together with the Capital Stock of the
Company, being referred to collectively as “Company Securities”) and (D) no other obligations by the Company or any of Company Subsidiary to make any payments based on the price or value of any Company Securities. Except
as set forth in Section 2(g) of the Disclosure Schedule, there are no outstanding Contracts of any kind which obligate the Company or any Company Subsidiary to repurchase, redeem or otherwise acquire any Company Securities. All of the
issued and outstanding shares of the Company’s Capital Stock have been and all shares reserved for issuance will on issuance be, duly authorized, validly issued, fully paid and non-assessable. Except as set forth in Section 2(g) of
the Disclosure Schedule, neither the Company nor any Company Subsidiary is subject to any obligation (contingent or otherwise) to repurchase or otherwise acquire or retire any of its Capital Stock. Except as set forth in Section 2(g) of
the Disclosure Schedule, neither the Company nor any Company Subsidiary is a party to any agreement relating to the voting of, transfer of, requiring registration of, or granting any preemptive rights, anti-dilutive rights or rights of first refusal
or other similar rights with respect to any securities of the Company, including any Contract granting any Person the right to require the Company to file a registration statement under the 1933 Act (as defined below) or to require the Company to
include any securities in any other registration statement filed by the Company under the 1933 Act. 

  

	 	ii.	After giving pro forma effect to the transactions contemplated hereby, Section 2(g)(ii) attached hereto sets forth, as of the close of business on
the Business Day immediately preceding the date hereof, a true, complete and correct listing of all the Company’s outstanding: (i) shares of the Common Stock and (ii) Derivative Securities, including the applicable exercise price of
such Derivative Securities, other than any Derivative Securities issued pursuant to the Company’s Amended and Restated Equity-Based Compensation Plan or the Company’s 2011 Employee Stock Purchase Plan. 

(h) SEC Reports; Financial Statements. 

 

	 	i.	 As of its filing date, the Form 10-K filed by the Company with the Securities and Exchange Commission (the “SEC”) on
April 16, 2012, as amended by the Form 10-K/As filed with the SEC on April 30, 2012, and May 3, 2012 (the “2011 Form 10-K”), complied in all material respects

  
 5 

	 	
with the applicable requirements of the Securities Act of 1933, as amended (the “1933 Act”), the Securities Exchange Act of 1934, as amended (the “1934
Act”), and the Sarbanes-Oxley Act of 2002, as the case may be, including, in each case, the rules and regulations promulgated thereunder. The Company has filed all other reports, registration statements, proxy statements and other
materials, together with any amendments required to be made with respect thereto, that were required to be filed with the SEC under the 1933 Act or the 1934 Act prior to the date hereof (all such reports and statements required to be filed on or
after January 1, 2011 are collectively referred to herein together with the 2011 Form 10-K as the “Company SEC Documents”). As of their respective dates, the Company SEC Documents, including the financial statements
contained therein, complied in all material respects with all of the statutes and published rules and regulations enforced or promulgated by the regulatory authority with which the Company SEC Documents were filed, and, except to the extent that
information contained in any Company SEC Document has been revised or superseded by a document the Company subsequently filed with the SEC, the Company SEC Documents do not contain any untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. None of the Company’s Subsidiaries is required to file any forms, reports or
other documents with the SEC. No executive officer of the Company has failed to make the certifications required of him or her under Section 302 or 906 of the Sarbanes-Oxley Act with respect to any Company SEC Document. Neither the Company nor
any of its executive officers has received notice from any Governmental Body challenging or questioning the accuracy, completeness, form or manner of filing of such certifications. 

 

	 	ii.	 (A) The financial statements (including the notes related thereto) included in the Company SEC Documents, including the 2011 Form 10-K, comply as to
form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto, have been prepared in accordance with United States generally accepted accounting principles
(“GAAP”) (except, in the case of unaudited statements, as permitted by the SEC) applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto) and fairly present in all material
respects the consolidated financial position of the Company and the Company Subsidiaries as of the dates thereof and their respective consolidated results of operations and cash flows for the periods then ended (subject, in the case of unaudited
statements, to normal and recurring year-end audit adjustments that were not, or are not expected to be, material in amount), all in accordance with GAAP and the applicable rules and regulations promulgated by the SEC. Since December 31, 2011,
the Company has not made any change in the accounting practices or policies applied in the preparation of its financial 

  
 6 

	 	
statements, except as required by GAAP, the rules of the SEC or policy or applicable Law. (B) The consolidated balance sheet of the Company and the Company Subsidiaries as of
December 31, 2011 included in the 2011 Form 10-K reflects, in each case as of December 31, 2011, all amounts borrowed and indebtedness incurred under the Debt Facilities or otherwise by the Company or any Company Subsidiary, and all loans
or advances made by the Company or any Company Subsidiary to any Person. 

  

	 	iii.	The Company has established and maintains a system of internal accounting controls designed to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements in accordance with GAAP, including policies and procedures that are designed to (A) require the maintenance of records that in reasonable detail accurately and fairly reflect the
transactions and dispositions of the assets of the Company and the Company Subsidiaries, (B) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and
that receipts and expenditures of the Company and the Company Subsidiaries are being made only in accordance with appropriate authorizations of management and the Company’s Board of Directors (the “Board”) and
(C) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the assets of the Company and the Company Subsidiaries. Except as set forth in Section 2(h)iii of the
Disclosure Schedule or disclosed in the Company SEC Documents, neither the Company nor, to the knowledge of the Company, the Company’s independent auditors, has identified or been made aware of (1) any significant deficiency or material
weakness, in each case which has not been subsequently remediated, in the system of internal accounting controls utilized by the Company and the Company Subsidiaries, taken as a whole, or (2) any fraud that involves the Company’s
management or other employees who have a role in the preparation of financial statements or the internal accounting controls utilized by the Company. 

(i) Absence of Certain Developments. Except as set forth in Section 2(i) of the Disclosure Schedule,
since December 31, 2011: 
  

	 	i.	neither the Company nor any Company Subsidiary has borrowed any amount, incurred any indebtedness under the Debt Facilities or otherwise or become subject to any
contingent obligations, or made any loans or advances to any Person; 

  

	 	ii.	no change, development, event, effect, condition or contingency has occurred which, individually or in the aggregate, has had or would reasonably be expected to have a
Material Adverse Effect; 

  
 7 

	 	iii.	neither the Company nor any Company Subsidiary has transferred, issued, sold, encumbered, pledged, or disposed of any shares of their Capital Stock or granted any
options, warrants, calls or other rights to purchase or otherwise acquire shares of their Capital Stock other than under the Company’s employee stock option plans and the dissolution of former Company Subsidiaries, or declared or made any
payment or distribution of cash or other property with respect to shares of their Capital Stock, or purchased or redeemed any shares of Capital Stock; 

  

	 	iv.	there has not been any damage, destruction or loss, whether or not covered by insurance, with respect to the property of the Company or any Company Subsidiary which,
individually or in the aggregate, has had or would reasonably be expected to have a Material Adverse Effect; 

  

	 	v.	neither the Company nor any Company Subsidiary has entered into, modified or amended any Material Contract, or terminated any Contract that would have been a Material
Contract if such Contract were in effect as of the date hereof other than as disclosed by the Company in the Company SEC Documents; and 

  

	 	vi.	neither the Company nor any Company Subsidiary has amended its Certificate of Incorporation, Bylaws or other organizational documents except as contemplated by this
Agreement. 

  

	 	(j)	Preferred Stock Exemption. The offer and sale of the Purchased Shares by the Company to each Purchaser pursuant to and in the manner contemplated by this
Agreement will be exempt from the registration requirements of the 1933 Act. Neither the Company nor any Person acting at its direction has taken any action (including any offering of any securities or Capital Stock of the Company under
circumstances which would require the integration of such offering with the offering of any of the Purchased Shares pursuant to this Agreement under the 1934 Act and the rules and regulations of the SEC thereunder) which would subject the offering,
issuance, exchange or sale of any of the Purchased Shares to any Purchaser pursuant to this Agreement to the registration requirements of the 1934 Act. 

  

	 	(k)	Debt Facility Compliance. Except to the extent waived or otherwise cured in accordance with the terms thereof, the Company has complied in all material respects
with the covenants set forth in (i) that certain Loan Security Agreement, dated as of November 22, 2010, by and among the Company, the guarantors and lenders from time to time party thereto, Wells Fargo Bank, National Association, as
agent, and Wells Fargo Capital Finance, LLC, as sole lead arranger, manager and bookrunner (the “Credit Facility”), including without limitation Section 4 thereof, and (ii) that certain Second Lien Letter of Credit,
Loan and Security Agreement, dated September 20, 2011, by and among the Company, as borrower, the guarantors and lenders party from time to time thereto and Ares Capital Corporation, as agent (the “LC Facility” and
together with the Credit Facility, the “Debt Facilities”). Immediately following the consummation of the transactions contemplated hereby, the Company will be in compliance in all material respects with the covenants set
forth in the Debt Facilities. Immediately following the repayment of any Purchase Price required under Section 9.7(b)(iii)(D) of the Credit Facility, the Company will be able to redraw amounts equal to at least such Purchase Price.

  
 8 

	 	(l)	No Brokers. Except as set forth in Section 2(l) of the Disclosure Schedule, no agent, broker, investment banker, finder, financial advisor or other
Person is or will be entitled to any broker’s or finder’s fee or any other commission or similar fee as a result of actions taken by the Company or its Affiliates, directly or indirectly, as a result of, or in connection with the
transactions contemplated by this Agreement. 

  

	 	(m)	Litigation. There are no Legal Proceedings pending or, to the knowledge of the Company, threatened, that question the validity of this Agreement or the
Transaction Documents or any action taken or to be taken by the Company or any Company Subsidiary in connection with the consummation of the transactions contemplated hereby. Except as disclosed in the Company SEC Documents or in Section
(m) of the Disclosure Schedule, there are no Legal Proceedings pending or, to the knowledge of the Company, threatened, against the Company or any Company Subsidiary or any of their respective properties or assets, at Law or in equity,
involving claims of more than $50,000 or that if determined adversely to the Company or any Company Subsidiary would, individually or in the aggregate, have or would reasonably be expected to have a Material Adverse Effect. There is no outstanding
or, to the knowledge of the Company, threatened, Order of any Governmental Body against the Company or any Company Subsidiary or any of their respective properties or assets. There is no action, suit, proceeding or investigation by the Company
currently pending or that the Company currently intends to initiate. 

  

	 	(n)	Employee Benefit Plans. 

  

	 	i.	With respect to any Benefit Plan, no Legal Proceeding has been asserted, instituted, or, to the knowledge of the Company, is threatened or anticipated (other than
routine claims for benefits, and appeals of such claims) that would, individually or in the aggregate, have or reasonably be expected to have a Material Adverse Effect. 

 

	 	ii.	Each Benefit Plan has been established and administered in all material respects in accordance with its terms, and is in material compliance with the applicable
provisions of ERISA, the Code and all other applicable Laws, rules and regulations. 

  

	 	iii.	 Neither the Company, any Company Subsidiary, nor any other entity which, together with the Company or any Company Subsidiary would be treated as a
single employer under Section 4001 of ERISA or Section 414 of the Code (each such entity, an “ERISA Affiliate”) sponsors, maintains, contributes to, or has had an obligation at any time to sponsor, maintain or
contribute to, or has had or has any liability in respect of any “employee benefit plan” (as defined in Section 3(3) of ERISA) subject to Section 412 

  
 9 

	 	
of the Code or Section 302 of ERISA or Title IV of ERISA, including any “multiemployer plan” (as defined in Section 4001(a)(15) of ERISA), or any other plan which is subject
to Section 4063, 4064 or 4069 of ERISA. Neither the Company nor any Company Subsidiary has any material liability under any “employee pension benefit plan” (within the meaning of Section 3(2) of ERISA) that is not intended to be
qualified under Section 401(a) of the Code. Except as required by Section 4980B of the Code or any similar state or local Law, no Benefit Plan provides any post-retirement or post-employment medical, disability or life insurance benefits
or coverage to any Person. 

  

	 	iv.	Except as would not, individually or in the aggregate, have or reasonably be expected to have a Material Adverse Effect, with respect to any Benefit Plan,
(i) there has been no non-exempt prohibited transaction (within the meaning of Section 406 of ERISA or Section 4975 of the Code) with respect to any Benefit Plan that would reasonably be expected to subject the Company or any Company
Subsidiary to any tax or penalty imposed by Section 502 of ERISA, Section 4975 of the Code or otherwise, and (ii) no event has occurred and no condition exists that would reasonably be expected to subject the Company or any Company
Subsidiary, either directly or by reason of their affiliation with any ERISA Affiliate, to any tax, fine, Lien, penalty or liability imposed by or under any applicable Laws, rules and regulations, including ERISA and the Code.

  

	 	v.	Neither the execution of this Agreement nor the consummation of the transactions contemplated hereby, whether alone or in combination with any other event, and thereby
will (i) accelerate the time of payment or vesting or increase the amount of compensation or benefits due to any Company Employee, or (ii) give rise to any other liability or funding obligation under any Benefit Plan or otherwise,
including liability for severance pay, unemployment compensation or termination pay. 

  

	 	vi.	Except as would not, individually or in the aggregate, have or reasonably be expected to have a Material Adverse Effect, neither the Company nor any Company Subsidiary
has any plan, contract or commitment, whether legally binding or not, to create any additional employee benefit or compensation plans, policies or arrangements or, except as may be required by Law, to modify any Benefit Plan.

  

	 	(o)	Labor Relations. 

  

	 	i.	Except as set forth in Section 2(o) of the Disclosure Schedule (A) no current Company Employee is represented by a union; (B) to the knowledge of
the Company, no union organizing efforts have been conducted within the last three years or are now being conducted; (C) neither the Company nor any of the Company Subsidiaries is a party to any collective bargaining agreement or other labor
contract; and (D) to the knowledge of the Company, neither the Company nor any of the Company Subsidiaries currently is subject to or threatened by, a strike, picket, work stoppage, work slowdown or other material labor dispute.

  
 10 

	 	ii.	Except as would not, individually or in the aggregate, have or reasonably be expected to have a Material Adverse Effect, to the knowledge of the Company, (A) each
of the Company and each of the Company Subsidiaries is in material compliance with all applicable Laws relating to employment and (B) neither the Company nor any of the Company Subsidiaries has incurred any liability or obligation under the
Worker Adjustment and Retraining Notification Act or any similar state or local Law within the last six months which remains unsatisfied. 

  

	 	(p)	Compliance with Laws; Certain Operations. The Company and the Company Subsidiaries are in compliance in all material respects with all material Laws and Orders
promulgated by any Governmental Body applicable to the Company and the Company Subsidiaries or to the conduct of the business or operations of the Company and the Company Subsidiaries or the use of their rights, properties (including any leased
properties) and assets. Neither the Company nor any Company Subsidiary has received any written notice of violation or alleged material violation of any such Law or Order by any Governmental Body in any material respect that has not been resolved.
Neither the Company nor any Company Subsidiary has received written notice that it is the subject of an investigation by any Governmental Body which would, individually or in the aggregate, have or reasonably be expected to have a Material Adverse
Effect. The Company and each of the Company Subsidiaries have all Permits necessary for the conduct of their business, except where the failure to have such Permits would not, individually or in the aggregate, have or reasonably be expected to have
a Material Adverse Effect. 

  

	 	(q)	Real Property and Assets. The Company or a Company Subsidiary has good and valid title to, or has a valid leasehold interest in, or has a valid license to use,
the real property, tangible properties and physical assets used by it and necessary for the conduct of its business as presently conducted, located on its premises or shown on the consolidated balance sheet of the Company and the Company
Subsidiaries as of December 31, 2011 as included in the 2011 Form 10-K or acquired thereafter (except for properties and assets disposed of in the ordinary course of business since December 31, 2011), free and clear of all Liens that would
materially affect the value thereof or materially interfere with the use made thereof. 

  

	 	(r)	 Tax Matters. There are no material Taxes due and payable by the Company or any Company Subsidiary which have not been timely paid. Except as set
forth in Section 2(r) of the Disclosure Schedule, all Tax Returns required to be filed by, or on behalf of, the Company and the Company Subsidiaries have been timely filed, and all such Tax Returns were true, correct and complete in all
material respects. The unpaid Taxes of the Company and the Company Subsidiaries (i) did not as of the filing date of the 2011 Form 10-K exceed the reserve for Taxes (excluding any reserve for deferred Taxes established to reflect timing
differences between book 

  
 11 

	 	
and Tax income) set forth in the 2011 Form 10-K and (ii) will not exceed that reserve in accordance with the past custom and practice of the Company and the Company Subsidiaries in filing
Tax Returns. Each of the Company and each Company Subsidiary has duly and timely withheld and paid over to the appropriate Governmental Body all material Taxes and other amounts required to be so withheld and paid over for all periods under all
applicable Laws. Except for Liens for Taxes not yet due and payable, no Liens for Taxes exist upon the assets of the Company or any of the Company Subsidiaries. No material audits, investigations or other proceedings are pending or being conducted
with respect to Taxes of the Company or the Company Subsidiaries. There are in effect no waivers of applicable statutes of limitations with respect to Taxes for any year. As of the date hereof, neither the Company nor any of the Company Subsidiaries
(i) has ever been a member of an affiliated group filing a consolidated Tax Return (other than an affiliated or consolidated group of which the Company was the parent) or (ii) has any liability for Taxes of any Person arising from the
application of Treasury Regulation section 1.1502-6 or any analogous provision of state, local or foreign Law, or as a transferee or successor, by contract, or otherwise. Neither the Company nor any of the Company Subsidiaries will be required to
include amounts in income, or exclude items of deduction, in a taxable period beginning after the date of the Closing as a result of (i) a change in method of accounting occurring prior to the date of the Closing; (ii) an installment sale
or open transaction arising in a taxable period (or portion thereof) ending on or before the date of the Closing; (iii) a prepaid amount received, or paid, prior to the date of the Closing; (iv) deferred gains arising prior to the date of
the Closing; or (v) an election under Section 108(i) of the Code. Neither the Company nor any Company Subsidiary is a party to, or is bound by or subject to any obligation under any Tax sharing or Tax indemnity agreement or similar
contract or arrangement. Neither the Company nor any Company Subsidiary has engaged in any “listed transaction” within the meaning of Treasury Regulation Section 1.6011-4(b)(2). 

 

	 	(s)	Material Contracts. The Company and the Company Subsidiaries are not a party to or bound by any of the following Contracts except as described in or filed as an
exhibit to the Company SEC Documents (each, including any such Contracts listed in the Company SEC Documents, a “Material Contract,” and collectively, the “Material Contracts”):

  

	 	i.	any mortgages, indentures, guarantees, loans or credit agreements, security agreements or other Contracts relating to the borrowing of money or extension of credit to
or by the Company, other than accounts receivables and payables in the ordinary course of business and travel and similar advances to employees in the ordinary course of business consistent with past practice; 

 

	 	ii.	any joint venture, partnership, limited liability company, strategic alliance or other similar Contract relating to the formation, creation, operation, management or
control of any partnership or joint venture; 

  
 12 

	 	iii.	any Contracts relating to all mergers, consolidations, recapitalizations, reorganizations or similar transactions, or any acquisitions or dispositions material to the
Company, currently contemplated by the Company or that provide any ongoing material liabilities for payment of money, retention of liabilities, assets sold, indemnification or otherwise; 

 

	 	iv.	any Contract providing for the payment by the Company or the Company Subsidiaries of an amount in excess of $150,000 or to the Company or the Company Subsidiaries of an
amount in excess of $150,000; 

  

	 	v.	non-competition, non-solicitation or exclusive dealing Contracts or other Contracts that restrict or limit or purport to restrict or limit in any material respect the
ability of the Company or any of its Affiliates to solicit customers, potential employees or the manner or location in which the business of the Company or any of its Affiliates may be conducted; 

 

	 	vi.	any Contract the benefits of which will be increased by the consummation of the transactions contemplated hereby or the value of any of the benefits of which will be
calculated on the basis of any of the transactions contemplated by this Agreement; or 

  

	 	vii.	any other Contract the termination of which, or default under which, would, individually or in the aggregate, have or reasonably be expected to have a Material Adverse
Effect. 

 Each of the Material Contracts to which the Company or any Company Subsidiary is a party is in full
force and effect, and to the knowledge of the Company, the other party thereto. Neither the Company, nor to the knowledge of the Company, any other party to a Material Contract to which the Company or any Company Subsidiary is a party, is in breach
or violation of, or in default under, any such Material Contract to which it is a party and no event has occurred that, individually or in the aggregate, with the lapse of time or the giving of notice or both would constitute a default thereunder by
the Company, the Company Subsidiaries or, to the knowledge of the Company, by any other party thereto. 
  

	 	(t)	 Intellectual Property. Except as set forth in Section 2(t) of the Disclosure Schedule, the Company and the Company Subsidiaries own,
have the right to use or can acquire on commercially reasonable terms, all patents, inventions, trademarks, trade names, domain names, trade secrets, know-how, copyrights, software, code, systems, websites, networks, databases and all other
intellectual property rights (“Intellectual Property”) necessary to carry on its business as currently conducted. All registered or currently applied for Intellectual Property owned by the Company or any Company Subsidiary is
subsisting and unexpired, and to the knowledge of the Company, valid and enforceable. The Company and the Company Subsidiaries own or have the right to use, all Intellectual Property necessary for the conduct of its business as presently conducted.
The conduct of the Company’s and the Company Subsidiaries’ business does not infringe, misappropriate or violate (“Infringe”) the Intellectual Property of any Person,

  
 13 

	 	
there are no claims (including cease and desist letters or invitations to take a patent license) alleging the same. To the knowledge of the Company, no Person is Infringing any Intellectual
Property of the Company and the Company Subsidiaries. The Company and the Company Subsidiaries have taken reasonable security measures to protect and maintain their material Intellectual Property, and all Persons who have created, invented or
contributed to material Intellectual Property of the Company and any Company Subsidiary have assigned to the Company or a Company Subsidiary all of their rights therein. 

(u) Illegal Payments. The Company has never made any illegal payment of any kind, directly or indirectly,
including, without limitation, payments, gifts or gratuities, to the United States or any foreign national, state or local Governmental Body, employees or agents. 

(v) Related Party Transactions. No transaction has occurred or relationship exists between or among the Company or
any Company Subsidiary, on the one hand, and any of their respective related persons or Affiliates, on the other hand, that is required under Item 404 of Regulation S-K of the Securities Act to be described in the Company SEC Documents that is
not so described therein. Section 2(v) of the Disclosure Schedule sets forth any Contracts or other transactions (i) between Pegasus and any of its Affiliates (other than the Company and the Company Subsidiaries), on the one hand,
and the Company or any Company Subsidiary or any other Affiliate or related person of the Company, on the other hand; and (ii) between Pegasus and any of its Affiliates (other than the Company and the Company Subsidiaries), on the one hand, and
any other Person to the extent such Contract is on behalf of or for the benefit of the Company or any Company Subsidiary, and to the extent not described in the 2011 Form 10-K. As used in this Section 2(v), “related person”
shall have the meaning set forth in Item 404 of Regulation S-K promulgated under the Securities Act. 
 (w)
Insurance. Section 2(w) of the Disclosure Schedule provides a complete list of the Company’s fire and casualty, errors and omissions, directors and officers, or any other material insurance policy, currently in effect. The
policies listed in Section 2(w) of the Disclosure Schedule are in full force and effect, all premiums thereon have been paid when due, and, to the knowledge of the Company, the Company is otherwise in compliance in all material respects
with the terms and provisions of such policies. The Company has not received any notice of default, cancellation or non-renewal with respect to any such policy or arrangement nor, to the knowledge of the Company, has the termination of any such
policy or arrangement been threatened. 
 (x) Not an “Investment Company.” The Company and the
Company Subsidiaries are not, nor are they directly or indirectly controlled by or acting on behalf of any Person that is, an investment company within the meaning of the Investment Company Act of 1940, as amended. 

(y) Anti-takeover Provisions Not Applicable. No “moratorium,” “control share,” “fair
price,” “takeover,” “business combination” or “interested shareholder” or other similar anti-takeover statute or regulation (including any provision of the Company’s Certificate of Incorporation or Bylaws) is
applicable to the transactions contemplated by (and the Company and the Board have taken all necessary action, if any, in order to render any such statute, regulation or provision inapplicable to the Purchasers) this Agreement and/or the Transaction
Documents. 

  
 14 

 3. Purchaser Representations and Warranties. Each Purchaser, severally and not
jointly, represents and warrants with respect to itself to the Company as follows: 
 (a) Such Purchaser has the
full power and authority to execute and deliver this Agreement and to perform all of its obligations hereunder and thereunder, and to purchase, acquire and accept delivery of the Purchased Shares. 

(b) The Purchased Shares are being acquired for such Purchaser’s own account and not with a view to, or intention
of, distribution thereof in violation of the 1933 Act, or any applicable state securities Laws. 
 (c) Such
Purchaser is knowledgeable in financial matters and is able to evaluate the risks and benefits of an investment in the Purchased Shares. Such Purchaser understands and acknowledges that such investment is a speculative venture, involves a high
degree of risk and is subject to complete risk of loss. Such Purchaser has carefully considered and has, to the extent such Purchaser deems necessary, discussed with such Purchaser’s professional legal, tax, accounting and financial advisers
the suitability of its investment in the Purchased Shares. 
 (d) Such Purchaser is able to bear the economic
risk of its investment in the Purchased Shares for an indefinite period of time because the Purchased Shares have not been registered under the 1933 Act and, therefore, cannot be sold unless subsequently registered under the 1933 Act or an exemption
from such registration is available. Such Purchaser: (i) understands and acknowledges that the Purchased Shares being issued to such Purchaser have not been registered under the 1933 Act, nor under the securities Laws of any state, nor under
the Laws of any other country and (ii) recognizes that, other than with respect to the Company SEC Documents, no public agency has passed upon the accuracy or adequacy of any information provided to such Purchaser or the fairness of the terms
of its investment in the Purchased Shares. 
 (e) Such Purchaser has had an opportunity to ask questions and
receive answers concerning the terms and conditions of the offering of the Purchased Shares and has had full access to such other information concerning the Company as has been requested. 

(f) This Agreement constitutes the legal, valid and binding obligation of such Purchaser, enforceable in accordance with
its terms, and the execution, delivery and performance of this Agreement by such Purchaser does not and will not conflict with, violate or cause a breach of any agreement, contract or instrument to which such Purchaser is a party or any judgment,
order or decree to which such Purchaser is subject. 
 (g) Such Purchaser became aware of the offering of the
Purchased Shares other than by means of general advertising or general solicitation. 

  
 15 

 (h) Such Purchaser is an “accredited investor” as
that term is defined under the 1933 Act and Regulation D promulgated thereunder, as amended by Section 413 of the Private Fund Investment Advisers Registration Act of 2010 and any applicable rules or regulations or interpretations thereof
promulgated by the SEC or its staff. 
 (i) Such Purchaser acknowledges that the certificates for the Purchased
Shares will contain a legend substantially as follows: 
 “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE. THE SECURITIES MAY NOT BE TRANSFERRED EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR
PURSUANT TO AN APPLICABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF SUCH ACT AND SUCH LAWS. 
 Subject to any lock-up or
other similar agreement that may apply to the Purchased Shares as may be specifically agreed to with an applicable Purchaser, the requirement that the Purchased Shares contain the legend set forth in clause (i) above shall cease and terminate
when such shares are transferred pursuant to Rule 144 promulgated under the 1933 Act. Upon the consummation of an event described in the immediately preceding sentence, the Company, upon surrender of certificates containing such legend, shall, at
its own expense (without the need for any opinion of counsel for a Purchaser), deliver to the holder of any such securities as to which the requirement for such legend shall have terminated, one or more new certificates evidencing such securities
not bearing such legend. 
 4. Additional Agreements. 

(a) Rollover Rights. Each Purchaser acknowledges solely on behalf of itself the rights of the holders of the
Company’s Series G Preferred Stock to exchange the Liquidation Value (as defined in the Certificate of Designation of the Series G Preferred Stock) of the Series G Preferred Stock for Series H Preferred Stock or Series I Preferred Stock (the
“Rollover Rights”) pursuant to Section 4 of the Certificate of Designation of the Series G Preferred Stock as filed with the Secretary of State of the State of Delaware on December 1, 2011, as amended by the
Certificate of Increase of Series G Preferred Stock filed with the Secretary of State of the State of Delaware on February 24, 2012 and the Series G Subscription Agreements. The Company represents and warrants to each of the Purchasers that
each holder of Series G Units provided representations and warranties substantially identical to those set forth in Section 5 of the Series G Unit Subscription Agreement, dated December 1, 2011, by and among the Company, PCA LSG Holdings,
LLC, Pegasus Partners IV, L.P., LSGC Holdings II LLC, Ensemble Lights, LLC, Belfer Investment Partners L.P., Lime Partners, LLC, Mark Kristoff and Alan Docter, to, and for the benefit of, the Company in connection with their purchase or acquisition
of such Series G Units. As of the date hereof, holders of Series G Preferred Stock have exercised Rollover Rights to exchange (x) 4,346 shares of Series G Preferred Stock for shares of Series H Preferred Stock and (y) 49,995 shares of
Series G Preferred Stock for shares of Series I Preferred Stock. As of the date hereof, holders of all outstanding shares of Series G Preferred Stock have exercised the Rollover Rights and no shares of Series G Preferred

  
 16 

 
Stock will be outstanding immediately following the Closing. Promptly following the date hereof, the Company shall file a Certificate of Elimination to the Certificate of Incorporation
eliminating from the Certificate of Incorporation all matters set forth in the Certificate of Designation of the Series G Preferred Stock (the “Certificate of Elimination”). No Purchaser shall object to and each Purchaser
shall take all commercially reasonable actions to permit the Company to effect the exchanges of Series G Preferred Stock pursuant to the Rollover Rights and effect the transactions contemplated by the Certificate of Elimination as provided in this
Section 4(a). 
 (b) Purchase Covenant. Each Purchaser agrees, severally and not jointly as
to itself, not to make any sale, transfer or other disposition of the Purchaser Shares in violation of the 1933 Act, the 1934 Act, the rules and regulations promulgated thereunder or any applicable securities Laws. 

(c) Purchaser Expenses. The Company shall pay up to $750,000 in the aggregate of Primary Investor’s
reasonable and documented out-of-pocket fees and expenses, including the fees and expenses of attorneys, accountants and consultants employed by Primary Investor to the extent that such fees and expenses relate to services rendered in conjunction
with Primary Investor’s investment in the Series H Preferred Stock. 
 (d) Tax Provision. The
Company and each Purchaser intend that for U.S. federal, state and local income tax purposes, the Series H Preferred Stock and Series I Preferred Stock will be treated as equity and each of the Company and each Purchaser agrees that it will not take
any position to the contrary with respect to any Preferred Shares it acquires pursuant to the terms of this Agreement. 
 (e) Primary Investor Information Rights. For so long as Primary Investor owns in the aggregate at least 10,000 shares of Series H Preferred Stock (or the equivalent amount of Conversion Shares),
during normal business hours, the Company shall provide to Primary Investor reasonable access to customary information, access and inspection rights, including delivering to Primary Investor the following information (collectively, the
“Public Company Information”): 
  

	 	i.	on an annual basis and promptly after it has been made available (but no later than 30 days before the beginning of each fiscal year), (A) an annual budget of the
Company, (B) a business plan of the Company, and (C) financial forecasts for the next fiscal year of the Company, in each case to the extent and in such manner and form prepared by or for the Company’s Board; 

 

	 	ii.	on an annual basis and promptly after it has been made available (but no later than 75 days after the end of each fiscal year), annual unaudited financial and operating
reports of the Company, to the extent and in such manner and form prepared by or for the Board; 

  

	 	iii.	on a quarterly basis and promptly after it has been made available (but in no event later than 40 days after the end of each quarter), unaudited quarterly financial and
operating reports of the Company, to the extent and in such manner and form prepared by or for the Board; 

  
 17 

	 	iv.	final drafts of monthly management and operating reports of the Company as reasonably requested by the Primary Investor to the extent and in such manner and form
prepared by or for the Company’s chief executive officer and/or provided to the Board; and 

  

	 	v.	such other financial, management and operating reports and information reasonably requested by Primary Investor, including all such information as required for
customary reporting to the limited partners of Primary Investor’s Affiliates and for tax reporting purposes. 

In addition, for so long as Primary Investor owns in the aggregate at least 2,500 shares of Series H Preferred Stock (or the equivalent
amount of Conversion Shares), the Primary Investor shall have the right to designate up to two non-voting board observers who will be entitled to attend all meetings of the Board, participate in all deliberations of the Board and receive copies of
all materials provided to the Board; provided, that such observers shall have no voting rights with respect to actions taken or elected not to be taken by the Board; provided, further, that the Company shall be entitled to
exclude such observer from such portions of a meeting of the Board to the extent such observer’s presence would be reasonably likely to result in the waiver of attorney-client privilege or if the matter to be discussed at such Board meeting is
one in which such observer or its Affiliates has a conflict of interest with the Company. 
 In addition, in the event that the
Company is no longer obligated to file an annual report on Form 10-K or quarterly report on Form 10-Q with the SEC, the Company shall also deliver the following to Primary Investor (collectively, the “Private Company
Information” and together with the Public Company Information, the “Company Information”): 
  

	 	vi.	as soon as practicable after the end of each fiscal year of the Company, and in any event within ninety (90) days thereafter (to the extent practicable),
(A) a consolidated balance sheet of the Company and the Company Subsidiaries as of the end of such fiscal year and consolidated statements of income and cash flows of the Company and the Company Subsidiaries for such year, prepared in
accordance with GAAP and setting forth in each case in comparative form the figures for the previous fiscal year, all in reasonable detail and followed promptly thereafter (to the extent it shall be available) with the opinion of the independent
registered public accounting firm selected by the Company’s Audit Committee with respect to such financial statements; and 

  

	 	vii.	 in lieu of providing the information required under the foregoing Section 4(e)vi, as soon as practicable after the end of the first, second
and third quarterly accounting periods in each fiscal year of the Company, and in any event within forty-five (45) days thereafter (to the extent practicable), an unaudited consolidated balance sheet of the Company and the

  
 18 

	 	
Company Subsidiaries as of the end of each such quarterly period, and unaudited consolidated statements of income and cash flows of the Company and the Company Subsidiaries for such period and
for the current fiscal year to date, prepared in accordance with GAAP and setting forth in comparative form the figures for the corresponding periods of the previous fiscal year, subject to changes resulting from normal year-end audit adjustments,
all in reasonable detail, except that such financial statements need not contain the notes required by GAAP. 

Primary Investor, and each Affiliate of Primary Investor, receiving Company Information hereunder shall keep such Company Information
confidential and shall not provide access to such Company Information to any other Person; provided, that Primary Investor may provide access to such Company Information (A) to its agents, employees, directors, officers, trustees,
partners, Affiliates, attorneys, accountants, advisors, auditors, portfolio management services and investors having an obligation of confidentiality to Primary Investor in the ordinary course of Primary Investor’s business; (B) to
prospective transferees or purchasers of any of the Purchased Shares held by Primary Investor; provided, that any such prospective transferee or purchaser shall have agreed to keep the same confidential in accordance with the provisions of
this Section 4; (C) as required by Law, subpoena, judicial order or similar legal process; provided, that Primary Investor shall notify the Company prior to disclosure if permitted by Law; (D) in connection with any
litigation related to any Transaction Document or other agreement between Primary Investor or any of its Affiliates and the Company or any of its Affiliates or in connection with the exercise of any right or remedy under any such Transaction
Document or agreement; and (E) as may be required in connection with the examination, audit or similar investigation of Primary Investor or with respect to a request from any Governmental Body having jurisdiction over Primary Investor. The
foregoing confidentiality restriction shall not apply to any Company Information that is in the public domain, becomes part of the public domain after disclosure to Primary Investor other than due to a breach by Primary Investor of this
Section 4, was within Primary Investor’s possession or developed by it prior to being furnished with such information as evidenced by Primary Investor’s records, or becomes available to Primary Investor on a non-confidential
basis from a source other than the Company. 
 (f) Purchaser Information Rights. The Company shall
provide each Purchaser who on the date hereof purchases, and for so long thereafter as such Purchaser continues to beneficially own, at least 5,000 Preferred Shares with the following information: 

 

	 	i.	In the event the Company is obligated to file an annual report on Form 10-K or quarterly report on Form 10-Q with the SEC and fails to file any such Form 10-K or Form
10-Q within 60 days of the then-applicable filing deadline (as extended by Rule 12b-25 of the 1934 Act), then upon the written request of such Purchaser, the Company shall promptly provide such Purchaser (collectively, the “Late Company
Information”): 

  

	 	1.	in the case of a late Form 10-K, annual unaudited financial and operating reports of the Company, to the extent and in such manner and form prepared by or for the
Board; and 

  
 19 

	 	2.	in the case of a late Form 10-Q, unaudited quarterly financial and operating reports of the Company, to the extent and in such manner and form prepared by or for the
Board; 

  

	 	ii.	In the event the Company is no longer obligated to file an annual report on Form 10-K or quarterly report on Form 10-Q with the SEC, the Company shall deliver the
Private Company Information to such Purchaser. 

 Any such Purchaser receiving the Late Company
Information or the Private Company Information hereby agrees on behalf of itself and its Affiliates to keep such Late Company Information and the Private Company Information confidential in the same manner, and to the same extent, as Primary
Investor has agreed to keep Company Information confidential pursuant to Section 4(e) of this Agreement. 
 (g) Effect of Qualified Public Offering. After consummation of a Qualified Public Offering, to the fullest extent permitted by the 1934 Act, the rules of The Nasdaq Stock Market or the New York
Stock Exchange, as applicable, on which the Common Stock is listed or traded and any other applicable Laws, for so long as Primary Investor and its Affiliates own in the aggregate Common Stock issued upon conversion of at least 10,000 shares of
Series H Preferred Stock: 
  

	 	i.	Primary Investor shall have the right to designate at each annual or special meeting of stockholders of the Company at which members of the Board are to be elected, and
the Company shall nominate and recommend for election at such meeting, that number of nominees (rounded to the nearest whole number) equal to the product of (x) the total number of members then comprising the full Board and (y) the
percentage of the Company’s outstanding Capital Stock beneficially owned at such time by Primary Investor and its Affiliates in the aggregate. The Company agrees to use the same efforts to cause Primary Investor’s designees pursuant to
this Section 4(g)i to be elected to the Board as it uses to cause other nominees of the Company to the Board to be elected. 

  

	 	ii.	 Without the prior written consent of Primary Investor, the Company shall not enter into any new agreements or transactions or series of agreements or
transactions with any Affiliate of the Company or Pegasus or any other holder of 5% or more of the Company’s Capital Stock or any Affiliates of any such stockholder of the Company (a “Related Party Agreement”) or amend or
modify the terms of any existing Related Party Agreements, other than: (A) up to $16.3 million payable pursuant to the LSGC Letter Agreement as in effect as of date hereof, (B) up to $500,000 in the aggregate of fees or other amounts
payable annually by the Company to Pegasus pursuant to any management or similar services agreement and (C) up to $200,000 in the aggregate of fees or other amounts payable annually by the Company to Primary Investor or any of its Affiliates
pursuant to the Support Services Agreement or any other management or similar services agreement, and shall not enter into any definitive agreement or commitment with respect to any of the foregoing or

  
 20 

	 	
indirectly engage in any of the foregoing through an affiliated Person (including without limitation Pegasus), including cause or permit any Subsidiary to engage in or enter into any definitive
agreement or commitment with respect to any of the foregoing. 

  

	 	iii.	Notwithstanding the foregoing, if after the date of this Agreement there is a change in the applicable rules of The Nasdaq Stock Market or the New York Stock Exchange,
that at the time such change becomes effective that would cause the Common Stock not to be initially listed or traded on, or to be delisted by, such exchange as a result of the terms of this Section 4(g), the rights of Primary Investor
set forth in this Section 4(g), shall thereafter be limited to the extent required by such changed rules for the Common Stock to be initially listed or traded or continue to be listed or traded on such exchange. In addition, if the lead
underwriter(s) of the Qualified Public Offering reasonably concludes and advises the Company that the Common Stock will not be able to be sold in such Qualified Public Offering within a price range acceptable to the Company unless the rights set
forth in this Section 4(g) are limited, then the Company shall use commercially reasonable efforts to accommodate the rights of Primary Investor set forth in this Section 4(g) but such rights may be limited to the extent
required by such underwriter(s) in order to achieve such price range. 

 (h) Terms of the
Preferred Shares. Each of the parties hereto acknowledges that the Series H Preferred Stock and Series I Preferred Stock (as applicable) shall each have the powers, preferences and rights, and be subject to the qualifications, limitations or
restrictions, in each case, set forth in the Series H Certificate of Designation or Series I Certificate of Designation, respectively, including those set forth in the last sentence of Section 5(c) thereof. 

(i) Current Public Information. The Company agrees to use its commercially reasonable efforts to make and keep
current public information available, within the meaning of Rule 144 or any similar or analogous rule promulgated under the Securities Act, at all times after the Closing. 

(j) Certain Actions. Promptly following the date hereof, the Company shall take all actions required to promptly
prepare and file any required notice of exempt offering of securities, including a Form D, with the SEC pursuant to the 1934 Act and/or other comparable form with state securities regulators with respect to any applicable “blue sky” laws,
in each such case, with respect to the transactions contemplated hereby, including the exercise of Rollover Rights contemplated in Section 4(a). 
 5. Indemnification by the Company. 
 (a) Subject to the
limitations and other provisions of this Section 5, The Company shall save, defend, indemnify and hold harmless each Purchaser and its affiliates and the respective representatives, directors, officers, employees, members, managers,
partners, stockholders, controlling Persons, agents, representatives, successors 

  
 21 

 
and assigns of each of the foregoing from and against any and all losses, damages, liabilities, deficiencies, claims, interest, awards, judgments, penalties, costs and expenses (including
reasonable out-of-pocket attorneys’ fees, costs and other out-of-pocket expenses incurred in investigating, preparing or defending the foregoing), asserted against, incurred, sustained or suffered by any of the foregoing as a result of, arising
out of or relating to any breach of any representation, warranty or covenant made by the Company and contained in this Agreement and Disclosure Schedule. 
 (b) Each Purchaser shall give notice to the Company promptly after such Purchaser has actual knowledge of any claim as to which indemnity may be sought, and to the extent such claim is a third party
claim, shall permit the Company to assume the defense of any such third party claim or any litigation resulting therefrom; provided, that counsel for the Company who shall conduct the defense of such third party claim or any litigation
resulting therefrom shall be approved by Primary Investor, if it is seeking indemnification hereunder, or, in any other circumstances, each applicable Purchaser (such approval by Primary Investor or any other applicable Purchasers shall not
unreasonably be withheld conditioned or delayed), and each applicable Purchaser may participate in such defense at its expense (other than as provided below), and provided further, that the failure of any applicable Purchaser to give notice
as provided herein shall not relieve the Company of its obligations under this Agreement, except to the extent that the Company is actually and materially prejudiced thereby. Each Purchaser, at the Company’s cost and expense, shall furnish such
information regarding itself or the claim in question as the Company may reasonably request and as shall be reasonably required in connection with the defense of any such third party claim and/or litigation resulting therefrom. Each Purchaser shall
have the right to retain its own counsel, with the fees and expenses to be paid by the Company, if (i) the Company fails to prosecute the applicable third party claim or litigation resulting therefrom in a prompt and timely fashion and/or
(ii) representation of such Purchaser by the counsel retained by the Company would be inappropriate due to actual or potential differing interests between such Purchaser and any other party represented by such counsel in such proceeding;
provided, that in no event shall the Company be required to pay the fees and expenses of more than one such separate counsel (other than foreign counsel) for the Purchasers unless and to the extent that representation of a Purchaser by the
counsel retained by the Company or by or on behalf of another Purchaser would be inappropriate due to actual or potential differing interests between or among the Company and/or such Purchasers, provided, further, that if Primary
Investor is seeking indemnification hereunder, it shall be entitled to select the counsel on behalf of all Purchasers contemplated by this sentence. Notwithstanding anything in this Section 5(b) to the contrary, neither the Company nor
any Purchaser shall, without the prior written consent of the other party, settle or compromise any third party claim as to which indemnity may be sought or permit a default or consent to entry of any judgment unless the claimant (or claimants) and
such party provide to such other party an unqualified release from all liability in respect of such third party claim; provided, that Primary Investor’s prior written consent shall be required for the Company to take any of such actions
if the taking of such actions could or could reasonably be expected to reduce or limit the rights or indemnification recoveries available to, or otherwise increase the liability of or Losses to, Primary Investor, its affiliates and their respective
representatives, directors, officers, employees, 

  
 22 

 
members, managers, partners, stockholders, controlling Persons, agents, representatives, successors and assigns. If the Company makes any payment on any claim, the Company shall be subrogated, to
the extent of such payment, to all rights and remedies of the applicable Purchaser to any insurance benefits or other claims of such Purchaser with respect to such claim. 

(c) Survival. The representations and warranties of the parties set forth in this Agreement and the other
Transaction Documents shall survive for a period of eighteen (18) months following the Closing and thereafter shall be of no further force or effect; provided, that the representations and warranties set forth in Sections
2(h)ii(B) (Balance Sheet Indebtedness), 2(i)i (Absence of Changes in Indebtedness), 2(r) (Tax Matters), 2(t) (Intellectual Property) and 2(v) (Related Party Transactions) shall survive for the applicable period of the
statute of limitations and the representations and warranties set forth in Sections 2(a) (Organization), 2(b) (Power), 2(c) (Subsidiaries), 2(d)i (Authorization), 2(e) (Capital), 2(g) (Capitalization) shall
survive indefinitely (or if indefinite survival is not permitted by Law, then for the maximum period permitted by applicable Law). Following the expiration of the periods set forth above with respect to any particular representation or warranty, no
party hereto shall have any further liability with respect to such representation or warranty. Except as set forth herein, all of the covenants, agreements and obligations of the parties hereto shall survive the Closing indefinitely (or if
indefinite survival is not permitted by Law, then for the maximum period permitted by applicable Law). Anything herein to the contrary notwithstanding, any claim for indemnification that is asserted by written notice within the survival period shall
survive until resolved pursuant to a final non-appealable judicial determination or a written agreement between the Company and the applicable Purchaser(s) who has made such indemnification claim. 

6. General Provisions. 
 (a) Definitions. As used herein, the following terms shall have the following meanings: 
 “Affiliate” shall mean any Person which directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with such Person or
entity; provided, however, that for purposes of the definition of “Affiliate,” Purchaser shall not be deemed an “Affiliate” of the Company. 

“Agreement” shall have the meaning set forth in the preamble. 

“Benefit Plan” shall mean each “employee benefit plan” (within the meaning of
Section 3(3) of ERISA), and each stock purchase, stock option, severance, employment, change-in-control, retention, fringe benefit, collective bargaining, bonus, incentive, deferred compensation, employee loan and all other similar employee
benefit plans, agreements, programs, policies or other arrangements, whether or not subject to ERISA, under which any Company Employee has any present or future right to benefits and which are contributed to, sponsored by or maintained by the
Company or any Company Subsidiary for such Company Employee. 

  
 23 

 “Bylaws” shall mean, when used with respect to a
specified Person, the bylaws of a Person, as the same may be amended from time to time. 
 “Capital
Stock” shall mean, with respect to any Person, any and all shares, shares of beneficial interest, interests, participations, rights in or other equivalents (however designated and whether voting or non-voting) of such Person’s
capital stock or any form of membership, ownership or participation interests, as applicable, including partnership interests, whether now outstanding or hereafter issued and any and all securities, debt instruments, rights, warrants or options
exercisable or exchangeable for or convertible into such capital stock. 
 “Certificate of
Elimination” shall have the meaning set forth in Section 4(a). 

“Certificate of Incorporation” shall mean, when used with respect to a specified Person, the
articles or certificate of incorporation or other applicable organizational document of such Person, including any certificate of designation, as currently in effect. 

“Closing” shall have the meaning set forth in Section 1(a). 

“Code” shall mean the Internal Revenue Code of 1986, as amended, and the rules and regulations
promulgated thereunder. 
 “Common Stock” shall have the meaning set forth in the
recitals. 
 “Company” shall have the meaning set forth in the preamble. 

“Company Employee” shall mean each current or former employee, director or individual independent
contractor of the Company or any Company Subsidiary. 
 “Company Information” shall have
the meaning set forth in Section 4(e). 
 “Company SEC Documents” shall have
the meaning set forth in Section 2(h)i. 
 “Company Subsidiary” and
“Company Subsidiaries” shall have the meaning set forth in Section 2(c). 

“Consents” shall mean all governmental and third party consents, approvals, filings,
authorizations, qualifications and waivers necessary to be received or made by a Person. 

“Contract” shall mean any legally binding contract, agreement, mortgage, deed of trust, bond,
loan, indenture, lease, license, note, option, warrant, right, instrument, commitment or other similar document, arrangement or agreement, whether written or oral, together with all amendments, modifications and/or supplements thereof. 

  
 24 

 “Conversion Shares” shall have the meaning set forth
in Section 2(d)i. 
 “Credit Facility” shall have the meaning set forth in
Section 2(k). 
 “Debt Facilities” shall have the meaning set forth in
Section 2(k). 
 “Derivative Securities” shall have the meaning set forth in
Section 2(g). 
 “Disclosure Schedule” shall have the meaning set forth in
Section 2. 
 “ERISA” means the Employee Retirement Income Security Act of
1974, as amended. 
 “GAAP” shall have the meaning set forth in
Section 2(h)ii. 
 “Governmental Body” shall mean any government or
governmental or quasi governmental authority including, without limitation, any federal, state, territorial, county, municipal or other governmental or quasi governmental agency, board, branch, bureau, commission, court, arbitral body (public or
private), department or other instrumentality or political unit or subdivision, whether located in the United States or abroad. 
 “Infringe” shall have the meaning set forth in Section 2(t). 
 “Intellectual Property” shall have the meaning set forth in Section 2(t). 
 “Late Company Information” shall have the meaning set forth in Section 4(f). 
 “Law” shall mean any treaty, statute, ordinance, code, rule, regulation, Order or other legal requirement enacted, adopted, promulgated, applied or followed by any Governmental
Body. 
 “LC Facility” shall have the meaning set forth in Section 2(k).

 “Legal Proceeding” shall mean any judicial, administrative or arbitral actions,
suits, claims, charges, complaints, demands, mediations, investigations or proceedings (public or private), governmental proceedings or stockholder actions, suits, claims, charges, complaints, demands, mediations, investigations or proceedings.

 “Lien” shall mean any mortgage, pledge, Lien (statutory or otherwise), security
interest, hypothecation, conditional sale agreement, encumbrance or similar restriction or agreement. 

“Material Adverse Effect” shall mean any event, change, effect, condition or contingency that has
a material adverse effect on the business, assets, liabilities (including contingent liabilities), results of operations or financial condition of the Company and the Company Subsidiaries, taken as a whole, other than to the

  
 25 

 
extent resulting from: (i) changes in general business or economic conditions affecting the industry generally in which the Company and the Company Subsidiaries operate, (ii) changes in
national or international political or social conditions, including the engagement by the United States of America in hostilities, whether or not pursuant to a declaration of a national emergency or war, or any escalation thereof, or the occurrence
of any military or terrorist attack upon the Unites States of America or any of its territories, possessions or diplomatic or consular offices or upon any military installation, equipment or personnel of the United States of America,
(iii) changes generally affecting financial, banking or securities markets (including any disruption thereof and any decline in the price of any security or any market index), (iv) changes in GAAP, or (v) changes in applicable Laws
(including any changes in interpretations thereof), in each case in the foregoing clauses (i) through (v), inclusive, which do not disproportionately affect the Company or the Company Subsidiaries as compared to other similarly situated
participants in the industry in which the Company and the Company Subsidiaries operate. 
 “Material
Contract” or “Material Contracts” shall have the meaning set forth in Section 2(s). 
 “1934 Act” shall have the meaning set forth in Section 2(h)i. 
 “1933 Act” shall have the meaning set forth in Section 2(h)i. 
 “Order” shall mean any order, injunction, judgment, decree, ruling, writ, assessment, mediation or arbitration award (whether temporary, preliminary or permanent). 

“Pegasus” shall mean Pegasus Capital Advisors, L.P. 

“Permits” shall mean any approvals, authorizations, licenses, permits, consents or certificates
by or of any Governmental Body. 
 “Person” shall mean any individual, corporation,
partnership, firm, limited liability company, joint venture, trust, association, unincorporated organization, group, joint stock company, Governmental Body or other entity. 

“Primary Investor” shall have the meaning set forth in the preamble. 

“Private Company Information” shall have the meaning set forth in Section 4(e).

 “Purchase Price” shall have the meaning set forth in the recitals. 

“Purchased Shares” shall have the meaning set forth in the recitals. 

“Purchasers” shall have the meaning set forth in the preamble. 

  
 26 

 “Qualified Public Offering” shall mean a firmly
committed underwritten public offering of the Common Stock on The NASDAQ Stock Market or the New York Stock Exchange pursuant to an effective registration statement filed under the 1933 Act, where (a) the gross proceeds received by the Company
and any selling stockholders in the offering are no less than $100 million and (b) the market capitalization of the Company immediately after consummation of the offering is no less than $500 million. 

“Registration Rights Agreement” shall mean the Registration Rights Agreement among the Company,
Primary Investor and Riverwood Management to be dated the date hereof, substantially in the form of Exhibit C. 
 “Riverwood Management” shall mean RW LSG Management Holding LLC. 
 “SEC” shall have the meaning set forth in Section 2(h)i. 
 “Series G Preferred Stock” shall mean the Company’s Series G Preferred Stock, par value $0.001 per share. 

“Series G Subscription Agreements” shall mean (i) that certain Subscription Agreement (the
“Series G Subscription Agreement”), dated as of December 1, 2011, by and among the Company, LSGC Holdings II LLC, PCA LSG Holdings, LLC and the other investors party thereto; (ii) the joinder to the Series G
Subscription Agreement executed by the investors party thereto; (iii) the Subscription Agreements, by and between the Company and Mr. Leon Wagner; and (iv) the Subscription Agreements, by and between the Company and PCA LSG Holdings,
LLC. 
 “Series G Units” shall mean the units of the Company’s securities which
consist of (i) one share of Series G Preferred Stock and (ii) 83 shares of Common Stock. 

“Series H Certificate of Designation” shall have the meaning set forth in the recitals.

 “Series H Preferred Stock” shall have the meaning set forth in the recitals.

 “Series I Certificate of Designation” shall have the meaning set forth in the
recitals. 
 “Series I Preferred Stock” shall have the meaning set forth in the
recitals. 
 “Subsidiary” shall mean (i) as to any Person, any other Person more
than 50% of the shares of the voting stock, voting interests, membership interests or partnership interests of which are owned or controlled, or the ability to select or elect more than 50% of the directors or similar managers is held, directly or
indirectly, by such first Person or one or more of its Subsidiaries or by such first Person and one or more of its Subsidiaries and/or (ii) any Person with respect to which the Company or a Company Subsidiary is a general partner or managing
member. 

  
 27 

 “Support Services Agreement” shall mean the Support
Services Agreement among the Company, Primary Investor and Riverwood Management to be dated the date hereof, substantially in the form of Exhibit D. 
 “Tax Return” shall mean any return, report, estimate, declaration, information return or other document (including any related, attached or supporting information) filed or
required to be filed with any taxing authority with respect to Taxes. 
 “Taxes” shall
mean all taxes, charges, fees, levies, penalties or other assessments imposed by any United States federal, state, local or foreign taxing authority, including, but not limited to, profits, estimated, gross receipts, windfall profits, severance,
property, intangible property, occupation, production, sales, use, license, excise, emergency excise, franchise, capital gains, capital stock, employment, withholding, transfer, stamp, escheat payroll, goods and services, value added, alternative or
add-on minimum tax, or any other tax, custom, duty or governmental fees or other taxes, including any interest, penalties, fines or additions attributable thereto, whether disputed or not. 

“Transaction Documents” shall mean this Agreement, the schedules and exhibits hereto, the Series
H Certificate of Designation, certificates evidencing the Purchased Shares, the Registration Rights Agreement, the Series I Certificate of Designation, the Warrant issued by the Company to Riverwood Management dated the date hereof and any
certificate or other document required to be delivered by or on behalf of the Company or any Purchaser pursuant to this Agreement or in connection with the transactions contemplated by this Agreement. 

“2011 Form 10-K” shall have the meaning set forth in Section 2(h)i. 

(b) Choice of Law. The Laws of the State of New York without reference to any conflict of Laws provisions thereof
that would result in the application of the Law of a different jurisdiction, will govern all questions concerning the construction, validity and interpretation of this Agreement. 

(c) Amendment and Waiver. The provisions of this Agreement may be amended and waived only with the prior written
consent of the Company and the applicable Purchaser, provided, that it is understood and agreed that no amendment or waiver of this Agreement shall be applicable to, or with respect to, any Purchaser without such Purchaser’s prior
written consent. No delay or failure of any Purchaser in exercising any right, power or remedy hereunder shall affect or operate as a waiver thereof, nor shall any single or partial exercise thereof or any abandonment or discontinuance of steps to
enforce such a right, power or remedy preclude any further exercise thereof or of any other right, power or remedy. The rights and remedies 

  
 28 

 
hereunder of each Purchaser are cumulative and not exclusive of any rights or remedies which it would otherwise have. Any waiver, permit, consent or approval of any kind or character on the part
of any Purchaser of any breach or default under this Agreement or any such waiver of any provision or condition of this Agreement must be in writing by such Purchaser and shall be effective only to the extent in such writing specifically set forth.

 (d) Counterparts. This Agreement may be executed in counterparts (including via facsimile or e-mail in
..pdf format), each of which shall be an original and all of which shall constitute a single agreement. 
 (e)
Effectiveness. It is understood that this Agreement is not effective and binding upon any of the parties hereto until executed and delivered by each of the parties hereto. 

(f) Headings. The headings contained in this Agreement are inserted for convenience only and will not affect in
any way the meaning or interpretation of this Agreement. 
 (g) Benefit of Agreement, Assignment. This
Agreement shall be binding upon and inure to the benefit of the Company and each Purchaser and their respective successors and assigns, heirs, executors and personal representative, as applicable, except that the Company shall not have the right to
assign any of its rights under this Agreement without the prior written consent of each Purchaser. Notwithstanding the foregoing, the rights of each Purchaser set forth herein shall inure to the benefit of such Purchaser and its transferees. This
Agreement is made solely for the benefit of the parties hereto and it is not the intention of the parties to confer third-party beneficiary rights upon any other Person other than any Person entitled to indemnity under Section 5 or as
set forth above, and no other Person shall have any rights, interest or claims hereunder or otherwise be entitled to any benefits under or on account of this Agreement as a third-party beneficiary or otherwise. 

(h) Notices. Any and all notices or other communications required or permitted to be delivered hereunder shall be
deemed properly delivered if (i) delivered personally, (ii) mailed by first class, registered or certified mail, return receipt requested, postage prepaid, (iii) sent by next day or overnight mail or delivery or (iv) sent by
electronic mail, facsimile transmission or other electronic means of transmitting written documents (with a follow up copy under (iii) above), to the parties as set forth below: 

If to Primary Investor: 
 c/o Riverwood Capital Management L.P. 
 70 Willow Road, Suite 100 

Menlo Park, CA 94025 
 Attention: Jeffrey T. Parks 
 Tel: (650) 618-7300 

Fax: (650) 618-7114 
 Email: jeff@rwcm.com 

  
 29 

 With a copy (which shall not constitute notice or constructive notice) to: 

Simpson Thacher & Bartlett LLP 
 2550 Hanover Street 
 Palo Alto, CA 94304 

Attention: Kirsten Jensen 
 Tel: (650) 251-5000 
 Fax: (650) 251-5002 

Email: kjensen@stblaw.com 
 If to the Company: 
 Lighting Science Group Corporation 

1227 South Patrick Drive 
 Building 2A 
 Satellite Beach, FL 32937 

Attention: Gregory T. Kaiser, Chief Financial Officer 
 Tel: (321) 779-5520 
 Fax: (321) 779-5521 

Email: greg.kaiser@lsgc.com 
 With a copy (which shall not constitute notice or constructive notice) to: 

Haynes and Boone, LLP 
 2323 Victory Avenue, Suite 700 
 Dallas, TX 75219 

Attention: Greg R. Samuel, Esq. 
 Tel: (214) 651-5645 
 Fax: (214) 200-0577 

Email: greg.samuel@haynesboone.com 
 Either party may change the name and address of the designee to whom notice shall be sent by giving written notice of such change to the other party. All notices or other communications to be, or
otherwise, provided by a Purchaser (other than Primary Investor) must be sent to both Primary Investor and the Company simultaneously in accordance with the procedures set forth in this Section 6(h) in order to be deemed properly delivered.

 (i) Entire Agreement. This Agreement, the Warrant, the Transaction Documents and all Exhibits and
Schedules attached here or thereto constitute the entire agreement and understanding between the Company and the Purchasers and the final expression thereof and supersede any and all prior agreements and understandings, written or oral, formal or
informal, between the Company and Purchasers relating to the subject matter hereof and thereof. 

  
 30 

 (j) Venue. Each of the parties hereto irrevocably consents to the
exclusive jurisdiction and venue of any state court located within New York, New York in connection with any matter based upon or arising out of this Agreement or the transactions contemplated hereby, agrees that process may be served upon them in
any manner authorized by the Laws of the State of New York for such Persons and waives and covenants not to assert or plead any objection which they might otherwise have to such jurisdiction, venue and process. Each party hereto hereby agrees not to
commence any legal proceedings relating to or arising out of this Agreement or the transactions contemplated hereby in any jurisdiction or courts other than as provided herein. 

(k) WAIVER OF JURY TRIAL. EACH PURCHASER AND THE COMPANY HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN
ANY ACTION, PROCEEDING OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE ACTIONS OF ANY PURCHASER OR THE COMPANY IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT HEREOF.

 (l) Rules of Construction. Words such as “herein,” “hereunder,” “hereof”
and the like shall be deemed to refer to this Agreement as a whole and not to any particular document or Article, Section or other portion in which such words appear. If a term is defined as one part of speech (such as a noun), it shall have a
corresponding meaning when used as another part of speech (such as a verb). Any reference to any federal, state, local or foreign statute, Law or other legal regulation shall be deemed to also to refer to all rules and regulations promulgated
thereunder. References herein to “$” shall be references to United States Dollars. The words “include” and “including” shall be deemed to mean “include, without limitation,” and “including, without
limitation”. 
 (m) Severability. Whenever possible, each provision of this Agreement shall be
interpreted in such manner as to be effective and valid under applicable Law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable Law in any jurisdiction, such provision shall be ineffective only to the
extent of such prohibition or invalidity, without invalidating any other provision of this Agreement. Upon such determination that any term or other provision is invalid, illegal or incapable of being enforced, the parties hereto shall negotiate in
good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated by this Agreement, the Warrant and the other Transaction
Documents be consummated as originally contemplated to the greatest extent possible. 
 (n) Independent
Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the
performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the
Purchasers as, and the Company acknowledges that the Purchasers do not so constitute, a partnership, an association, a joint venture or any other kind of entity, or create a 

  
 31 

 
presumption that the Purchasers are in any way acting in concert or as a group, and the Company shall not assert any such claim with respect to such obligations or the transactions contemplated
by the Transaction Documents and the Company acknowledges that the Purchasers are not acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. The Company acknowledges and each
Purchaser confirms that it has independently participated in the negotiation of the transaction contemplated hereby with the advice of its own counsel and advisors. A default by any Purchaser of its obligations pursuant to this Agreement shall not
constitute a default by any other Purchaser under this Agreement and, except with respect to such defaulting Purchaser, shall not relieve the Company of any of its obligations to any other Purchaser under this Agreement. Each Purchaser shall be
entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of any other Transaction Documents to which it is a party, and it shall not be necessary for any other Purchaser
to be joined as an additional party in any proceeding for such purpose. 
 [Remainder of page intentionally left blank]

  
 32 

 IN WITNESS WHEREOF, the parties hereto have executed this Agreement to be effective as of
the date first written above. 
  

					
	COMPANY:
	
	LIGHTING SCIENCE GROUP CORPORATION
		
	By:	 	 /s/ Gregory T. Kaiser

		 	Name:	 	Gregory T. Kaiser
		 	Title:	 	Chief Financial Officer

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	 PURCHASERS:

	
	 RW LSG HOLDINGS LLC

		
	By:	 	Riverwood Capital Management L.P.,
		 	its Managing Member
		
	By:	 	Riverwood Capital Management Ltd.,
		 	its General Partner
		
	By:	 	/s/ Michael E. Marks
		 	  

		 	Name: Michael E. Marks
		 	Title: Director and CEO

  
 34 

 
			
	9W INVESTMENT FUND I LP
		
	 By:
	 	9W Investment Partners LLC,
		 	its general partner
		
	 By:
	 	/s/ Brandon L. Jones
		 	  

		 	Name: Brandon L. Jones
		 	Title: Managing Member

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	KINGSBROOK OPPORTUNITIES MASTER FUND LP
		
	 By:
	 	 KINGSBROOK OPPORTUNITIES GP LLC,

its general partner

		
	 By:
	 	 /s/ Adam J. Chill

		 	 Name: Adam J. Chill

		 	 Title: Managing Member

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	THE MOELIS FAMILY TRUST
		
	 By:
	 	/s/ Kenneth Moelis
		 	  

		 	Name: Kenneth Moelis
		 	Title: Trustee

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Edmund P. Chiang

	 Edmund P. Chiang

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Scott S. DeGhetto

	 Scott S. DeGhetto

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Stuart Goldstein

	 Stuart Goldstein

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Richard Harding

	 Richard Harding

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Camilla Meyer

	 Camilla Meyer

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Yadin Rozov

	 Yadin Rozov

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	WADLER REVOCABLE TRUST UAD 3/16/01
		
	By:	 	/s/ Craig Wadler
		 	  

		 	Name: Craig Wadler
		 	Title: Managing Director

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	WADLER 2010 REVOCABLE TRUST
		
	By:	 	/s/ Todd J. Wadler
		 	  

		 	Name: Todd J. Wadler
		 	Title: Managing Director

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Vincent Lima

	 Vincent Lima

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	WEBBER TRUST DATED 3/15/04
		
	By:	 	/s/ Brian M. Webber
		 	  

		 	Name: Brian M. Webber

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	RAICH TRUST DATED SEPTEMBER 17, 2001
		
	By:	 	/s/ Jeffrey A. Raich
		 	  

		 	Name: Jeffrey A. Raich
		 	Title: Trustee

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	MAHMOODZADEGAN-GAPPY TRUST
		
	 By:
	 	/s/ Navid Mahmoodzadegan
		 	  

		 	Name: Navid Mahmoodzadegan
		 	Title: Authorized Signatory

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Dominick Petrosino

	 Dominick Petrosino

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Adam D. Sokoloff

	 Adam D. Sokoloff

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	ELIANA SARA SOKOLOFF 2503C TRUST
		
	 By:
	 	/s/ Adam D. Sokoloff
		 	  

		 	Name: Adam D. Sokoloff
		 	Title: Authorized Signatory

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	JULIA LEE SOKOLOFF 2503C TRUST
		
	 By:
	 	/s/ Adam D. Sokoloff
		 	  

		 	Name: Adam D. Sokoloff
		 	Title: Authorized Signatory

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	GABRIEL DAVID SOKOLOFF 2503C TRUST
		
	 By:
	 	/s/ Adam D. Sokoloff
		 	  

		 	Name: Adam D. Sokoloff
		 	Title: Authorized Signatory

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	ZELT GST TRUST
		
	 By:
	 	/s/ Adam D. Sokoloff
		 	  

		 	Name: Adam D. Sokoloff
		 	Title: Authorized Signatory

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	 SOKOLOFF FAMILY TRUST

		
	 By:
	 	/s/ Jonathan D. Sokoloff
		 	  

		 	Name: Jonathan D. Sokoloff
		 	Title: Authorized Signatory

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Irwin Simon

	 Irwin Simon

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Steven and Ann Van Dyke

	 Steven and Ann Van Dyke

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	 BHR Master Fund, Ltd.

		
	 By:
	 	/s/ William Brown
		 	  

		 	Name: William Brown
		 	Title: President

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	 BHR OC Master Fund, Ltd.

		
	 By:
	 	/s/ William Brown
		 	  

		 	Name: William Brown
		 	Title: President

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Andrew R. Heyer

	 Andrew R. Heyer

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Robert Stein

	 Robert Stein

 Signature Page to Preferred Stock Subscription Agreement 

 
			
	 2003 HOCHMAN FAMILY LLC

		
	 By:
	 	/s/ Richard H. Hochman
		 	  

		 	Name: Richard H. Hochman
		 	Title: Managing Member

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Nathaniel H. Hochman

	 Nathaniel H. Hochman

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Jason H. Hochman

	 Jason H. Hochman

 Signature Page to Preferred Stock Subscription Agreement 

 
	
	 /s/ Richard H. Hochman

	 Richard H. Hochman / Carol J. Hochman

 Signature Page to Preferred Stock Subscription Agreement 

 Schedule A 

 

											
	 Purchaser
	  	Series	  	Purchased
Shares	 	  	Total Cash
Consideration	 
	 RW LSG Holdings LLC
	  	Series H	  	 	50,000	  	  	$	50,000,000.00	  
	 9W Investment Fund I LP
	  	Series H	  	 	6,000	  	  	$	6,000,000.00	  
	 Kingsbrook Opportunities Master Fund LP
	  	Series H	  	 	2,000	  	  	$	2,000,000.00	  
	 The Moelis Family Trust
	  	Series H	  	 	500	  	  	$	500,000.00	  
	 Edmund P. Chiang
	  	Series H	  	 	100	  	  	$	100,000.00	  
	 Scott S. DeGhetto
	  	Series H	  	 	50	  	  	$	50,000.00	  
	 Stuart Goldstein
	  	Series H	  	 	25	  	  	$	25,000.00	  
	 Richard Harding
	  	Series H	  	 	50	  	  	$	50,000.00	  
	 Camilla Meyer
	  	Series H	  	 	200	  	  	$	200,000.00	  
	 Yadin Rozov
	  	Series H	  	 	30	  	  	$	30,000.00	  
	 Wadler Revocable Trust UAD 3/16/01
	  	Series H	  	 	25	  	  	$	25,000.00	  
	 Wadler 2010 Revocable Trust
	  	Series H	  	 	25	  	  	$	25,000.00	  
	 Vincent Lima
	  	Series H	  	 	50	  	  	$	50,000.00	  
	 Webber Trust dated 3/15/04
	  	Series H	  	 	25	  	  	$	25,000.00	  
	 Raich Trust dated September 17, 2001
	  	Series H	  	 	50	  	  	$	50,000.00	  
	 Mahmoodzadegan-Gappy Trust
	  	Series H	  	 	50	  	  	$	50,000.00	  
	 Dominick Petrosino
	  	Series H	  	 	25	  	  	$	25,000.00	  
	 Adam D. Sokoloff
	  	Series H	  	 	205	  	  	$	205,000.00	  
	 Eliana Sara Sokoloff 2503c Trust
	  	Series H	  	 	15	  	  	$	15,000.00	  
	 Julia Lee Sokoloff 2503c Trust
	  	Series H	  	 	15	  	  	$	15,000.00	  
	 Gabriel David Sokoloff 2503c Trust
	  	Series H	  	 	15	  	  	$	15,000.00	  
	 ZELT GST Trust
	  	Series H	  	 	625	  	  	$	625,000.00	  
	 Sokoloff Family Trust
	  	Series H	  	 	625	  	  	$	625,000.00	  
	 Irwin Simon
	  	Series I	  	 	500	  	  	$	500,000.00	  
	 Steven and Ann Van Dyke
	  	Series I	  	 	1,000	  	  	$	1,000,000.00	  
	 BHR Master Fund, Ltd.
	  	Series I	  	 	2,920	  	  	$	2,920,000.00	  
	 BHR OC Master Fund, Ltd.
	  	Series I	  	 	1,080	  	  	$	1,080,000.00	  
	 Andrew R. Heyer
	  	Series I	  	 	500	  	  	$	500,000.00	  
	 Robert Stein
	  	Series I	  	 	200	  	  	$	200,000.00	  
	 2003 Hochman Family LLC
	  	Series I	  	 	110	  	  	$	110,000.00	  
	 Nathaniel H. Hochman
	  	Series I	  	 	12	  	  	$	12,000.00	  
	 Jason H. Hochman
	  	Series I	  	 	12	  	  	$	12,000.00	  
	 Richard H. Hochman / Carol J. Hochman
	  	Series I	  	 	30	  	  	$	30,000.00	  
	 Total
	  		  	 	67,069	  	  	$	67,069,000.00	  
		  		  	  
	  
	 	  	  
	  
	 

  
 Schedule A

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00204-of-00352.parquet"}]]